10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

FORM 10-Q/A

_______________

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______to______.

REAC GROUP, INC.

(Exact name of registrant as specified in charter)

Florida	000-54845	59-3800845
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S Employer Identification No.)

3400 NW 74th Street

Miami, FL 33122

(Address of principal executive offices)

_______________

305-503-1200

(Registrant’s telephone number, including area code)

_______________

____________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer.	☐	Accelerated filer.	☐
Non-accelerated filer.	☐	Smaller reporting company.	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ☐     No ☒

As of June 1, 2021, there are 28,933,048 shares, par value $0.00001, of the issuer’s common stock issued and outstanding.

REAC GROUP, INC.

QUARTERLY REPORT ON FORM 10-Q

March 31, 2019

TABLE OF CONTENTS

		PAGE
PART 1 - FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	4
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3	Quantitative and Qualitative Disclosures About Market Risk	28
Item 4.	Controls and Procedures	28
PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	29
Item 1A.	Risk Factors	29
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	29
Item 3.	Defaults Upon Senior Securities	29
Item 4.	Mine Safety Disclosures	29
Item 5.	Other Information	29
Item 6.	Exhibits	30
SIGNATURES		31

2

CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION

This Quarterly Report on Form 10-Q (this “Report”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions, forward-looking statements may include words such as “anticipate,” “believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,” “seek,” “plan,” “might,” “will,” “expect,” “predict,” “project,” “forecast,” “potential,” “continue” negatives thereof or similar expressions. Forward-looking statements speak only as of the date they are made, are based on various underlying assumptions and current expectations about the future and are not guarantees. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or achievement to be materially different from the results of operations or plans expressed or implied by such forward-looking statements.

We cannot predict all of the risks and uncertainties. Accordingly, such information should not be regarded as representations that the results or conditions described in such statements or that our objectives and plans will be achieved and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. These forward-looking statements are found at various places throughout this Report and include information concerning possible or assumed future results of our operations, including statements about potential acquisition or merger targets; business strategies; future cash flows; financing plans; plans and objectives of management; any other statements regarding future acquisitions, future cash needs, future operations, business plans and future financial results, and any other statements that are not historical facts.

These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Report. All subsequent written and oral forward-looking statements concerning other matters addressed in this Report and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this Report.

Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

CERTAIN TERMS USED IN THIS REPORT

When this report uses the words “we,” “us,” “our,” and the “Company,” they refer to REAC Group, Inc. When this report uses “SEC”, it refers to the Securities and Exchange Commission.

EXPLANATORY NOTE

The Company is filing this amendment in order to correct errors made during the period presented. The original report filed on May 20, 2019 reported gains on forgiveness of debt related to two of the Company’s convertible notes payable. During the audit process for the Company’s 10-K annual report ending December 31, 2019, our auditors determined that the Company did not have sufficient and verifiable documentation to support the debt forgiveness previously recorded.

Therefore, and as a result, the Company recognizes that there is a material deficiency in its controls over financial reporting. Subsequent to the period ended March 31, 2019, the Company has undergone a change in control and new management has taken subsequent steps to alleviate deficiencies of this nature (See Part 1, Item 4). The effect of the restatement to the Company’s financial statements is disclosed in Footnote 3 to these financial statements.

3

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

Index to Financial Statements

REAC Group, Inc.

Contents

Financial Statements:	Page Number
Balance Sheets, as of March 31, 2019 (restated) and December 31, 2018	5
Statements of Operations for the three months ended March 31, 2019 (restated) and 2018	6
Statements of Stockholders’ deficit for the three months ended March 31, 2019 (restated) and 2018	7
Statements of Cash Flows for the three months ended March 31, 2019 (restated) and 2018	8
Notes to Financial Statements, as of March 31, 2019 (unaudited)	9

4

REAC GROUP, Inc.
Balance Sheets
	March 31, 2019			December 31, 2018
	(restated)
Assets
Current assets
Cash	$	261		$	1,162
Total current assets		261			1,162
Total assets	$	261		$	1,162
Liabilities and Stockholders’ Deficit
Current liabilities
Accounts payable	$	17,500		$	3,000
Accrued interest		78,677			54,119
Accrued salaries, payroll taxes and related expenses		931,948			807,108
Convertible notes payable, net of discounts of $-0- and $4,915, respectively		506,412			488,823
Due to principal shareholder, related party		10,795			-
Total current liabilities		1,545,332			1,353,050
Total liabilities		1,545,332			1,353,050
Commitments and Contingencies (Note 12)		-			-
Stockholders’ Deficit
Preferred Stock A, $.0001 par value,500,000 shares authorized; 500,000 and 500,000 issued and outstanding, respectively		50			50
Preferred Stock B, $.0001 par value, 500,000 shares authorized; none issued and outstanding		-			-
Common Stock, $0.00001 par value, 200,000,000 shares authorized; 15,057,517 and 50,441 shares issued and outstanding, respectively		150			-
Additional paid-in capital		25,038,765			22,034,695
Accumulated deficit		(26,584,036	)		(23,386,633	)
Total stockholders’ deficit		(1,545,071	)		(1,351,888	)
Total Liabilities and Stockholders’ Deficit	$	261		$	1,162
The accompanying notes are an integral part of these unaudited financial statements.

5

REAC GROUP, Inc.
Statements of Operations
(unaudited)
	For the Three Months Ended
	March 31,
	2019			2018
	(restated)
Revenues	$	-		$	-
Operating expenses:
Compensation and related costs		3,124,840			352,949
Professional		26,030			18,554
General and administrative		468			1,204
Total operating expenses		3,151,338			372,707
Loss from operations		(3,151,338	)		(372,707	)
Other income (expense):
Interest expense		(31,971	)		(18,334	)
Debt financing penalties		(14,094	)		-
Gain on write off of warrant liability		-			35,047
Total other income (expense)		(46,065	)		16,713
Loss before provision for income taxes		(3,197,403	)		(355,994	)
Provision for income taxes		-			-
Net (Loss)	$	(3,197,403	)	$	(355,994	)
(Loss) per share, basic and dilutive	$	(0.41	)	$	(18.27	)
Weighted average shares outstanding, basic and dilutive		7,784,185			19,486

The accompanying notes are an integral part of these unaudited financial statements.

6

REAC Group, Inc. Statements of Changes in Stockholders’ Deficit As of March 31, 2018 and 2019
	Series A Preferred Shares		Par Value		Common Shares		Par Value		Additional Paid in Capital		Accumulated Deficit			Total Deficiency
Balance as of December 31, 2017		50,935	$	5		9,364	$	-	$	21,483,185	$	(22,684,069	)	$	(1,200,879	)
In kind contribution of rent		-		-		-		-		300		-			300
Common shares issued as compensation and for services		-		-		10,000		-		330,000		-			330,000
Preferred shares issued as compensation and for services		449,065		45						112,221					112,266
Shares issued in satisfaction of loan debt and interest		-		-		5,931		-		45,430		-			45,430
Net loss for the three months		-		-		-		-		-		(355,994	)		(355,994	)
Balance as of March 31, 2018		500,000	$	50		25,295	$	-	$	21,971,136	$	(23,040,063	)	$	(1,068,877	)
* Shares retroactively restated for reverse stock split of 1:10,000 on March 1, 2019

	Series A Preferred Shares		Par Value		Common Shares		Par Value		Additional Paid in Capital		Accumulated Deficit			Total Deficiency
Balance as of December 31, 2018		500,000	$	50		50,441	$	-	$	22,034,695	$	(23,386,633	)	$	(1,351,888	)
In kind contribution of rent		-		-		-		-		300		-			300
Common shares issued as compensation and for services		-		-		15,000,000		150		2,999,850		-			3,000,000
Shares issued in satisfaction of loan debt and interest		-		-		4,900		-		3,920		-			3,920
Fractional shares issued in stock split						2,176		-		-		-			-
Net loss for the three months		-		-		-		-		-		(3,197,403	)		(3,197,403	)
Balance as of March 31, 2019		500,000	$	50		15,057,517	$	150	$	25,038,765	$	(26,584,036	)	$	(1,545,071	)

* Shares retroactively restated for reverse stock split of 1:10,000 on March 1, 2019

The accompanying notes are an integral part of these unaudited financial statements.

7

REAC GROUP, Inc.
Statements of Cash Flows
(unaudited)
	For the Three Months Ended
	March 31,
	2019			2018
	(restated)
Cash Flows from Operating Activities:
Net loss	$	(3,197,403	)	$	(355,994	)
Adjustment to reconcile net loss to net cash used in operations:
Stock based compensation		3,000,000			330,000
In kind contribution of rent		300			300
Amortization of debt discounts and financing costs		5,915			19,564
Debt financing penalties		14,094			-
Gain on write off of warrant liability		-			(35,047	)
Changes in assets and liabilities:
Accounts payable		14,500			-
Accrued interest		26,058			(1,230	)
Accrued salaries, payroll taxes and related expenses		124,840			3,683
Net Cash Used in Operating Activities		(11,696	)		(38,724	)
Cash Flows from Financing Activities:
Proceeds from notes payable, principal shareholder		11,355			-
Repayments of notes payable, principal shareholder		(560	)		(47	)
Net Cash (Used)/Provided by Financing Activities		10,795			(47	)
Net (decrease)/increase in cash		(901	)		(38,771	)
Cash at beginning of period		1,162			51,396
Cash at end of period	$	261		$	12,625
Supplemental cash flow information:
Interest paid	$	-		$	-
Taxes paid	$	-		$	-
Non-cash disclosures:
Common stock issued for principal and interest on convertible notes	$	3,920		$	45,430
Preferred stock issued against accrued officer compensation	$	-		$	112,266

The accompanying notes are an integral part of these unaudited financial statements.

8

REAC Group, Inc.

Notes to the Financial Statements

March 31, 2019

(unaudited)

1. Background Information

REAC Group, Inc. (“The Company”) was formed on March 10, 2005 under the name of Real Estate Contacts, Inc. as a Florida Corporation and is based in Pittsburgh, Pennsylvania. The Company changed its name to REAC Group, Inc. effective February 16, 2017. The Company engages in the ownership and operation of a real estate advertising portal website. The Company plans to provide a comprehensive online real estate search portal that consists of an advertising and marketing platform for real estate professionals. The Company’s national real estate search website is www.realestatecontacts.com.

The Company’s website offers cities to real estate professionals so they can grow their businesses online and have the opportunity to show their listings and reach consumers interested in buying or selling property in their respective exclusive geographic areas.

RealEstateContacts.com is expected to serve as an internet portal that will feature a real estate search website that directs consumers to receive more detailed information about agents, offices, and current listings, homes for sale, commercial properties, mortgages, and foreclosures. We intend to provide a service that enables real estate professionals to capture, cultivate, and convert leads which cater to prospective home buyers and sellers. The Company is seeking to bring additional value to its shareholders through acquisition, joint venture, or partnerships with other real estate related businesses. The Company intends to add to their business model by acquiring real estate such as multi-family and residential income producing properties. The Company is interested with the possibilities to Acquire, Joint Venture or Partner with other real estate related businesses along with other new business opportunities with established business entities and revenues. We will continue to introduce our operational progress and other corporate actions that include our plan of growth.

2. Summary of Significant Accounting Policies

Basis of Presentation

The Balance Sheet as of March 31, 2019, the Statements of Income for the three months ended March 31, 2019 and 2018, the Statements of Stockholders’ Deficit for the three months ended March 31, 2019 and 2018, and the Statements of Cash Flows for the three months ended March 31, 2019 and 2018 are unaudited. These unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP). In our opinion, the unaudited interim financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of March 31, 2019, our results of operations for the three months ended March 31, 2019 and 2018, and our cash flows for the three months ended March 31, 2019 and 2018. The results of operations for the three months ended March 31, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019.

These unaudited interim financial statements should be read in conjunction with the financial statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC.

All share and per share information contained in this report gives retroactive effect to a 1 for 10,000 reverse stock split of outstanding common stock, effective March 1, 2019.

Use of Estimates

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Our most significant estimates are for stock based compensation; assumptions used in calculating derivative liabilities, and deferred tax valuation allowances. We evaluate our estimates on an ongoing basis. Actual results may differ from these estimates under different assumptions or conditions.

Financial Instruments

The Company’s balance sheets include the following financial instruments: cash, accrued expenses, notes payable and payables to a stockholder. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. The carrying values of the notes payable and amounts due to stockholder approximates fair value based on borrowing rates currently available to the Company for instruments with similar terms and remaining maturities.

9

FASB Accounting Standards Codification (ASC) topic, “Fair Value Measurements and Disclosures”, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

· Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities

· Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

· Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2019.

Derivative Liabilities

The Company assessed the classification of its derivative financial instruments as of March 31, 2019 and 2018, which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815.

During the three months ended March 31, 2019 and 2018, respectively, the Company had notes payable outstanding in which the conversion rate was variable and undeterminable. The Company uses judgment in determining the fair value of derivative liabilities at the date of issuance and at every balance sheet thereafter and in determining which valuation method is most appropriate for the instrument, the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate, if any. For the three months ended March 31, 2019, the Company determined that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there was no derivative liability associated with these convertible notes for the period.

Beneficial Conversion Features

ASC 470-20 applies to convertible securities with beneficial conversion features that must be settled in stock and to those that give the issuer a choice in settling the obligation in either stock or cash. ASC 470-20 requires that the beneficial conversion feature should be valued at the commitment date as the difference between the conversion price and the fair market value of the common stock into which the security is convertible, multiplied by the number of shares into which the security is convertible. This amount is recorded as a debt discount and amortized over the life of the debt. ASC 470-20 further limits this amount to the proceeds allocated to the convertible instrument.

Cash Flow Reporting

The Company follows ASC 230, Statement of Cash Flows, for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.

Cash and Cash Equivalents

Cash is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed on demand and, therefore, bear minimal risk. The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company had no cash equivalents at either March 31, 2019 or 2018.

10

Long-Lived Assets

In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-lived asset exceeds its fair value.

Stock Based Compensation

Under ASC 718, Compensation – Stock Compensation, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

Equity instruments (“instruments”) issued to other than employees are recorded on the basis of the fair value of the instruments, as required by FASB ASC 718. FASB ASC No. 505, Equity Based Payments to Non-Employees (“ASC 505”) defines the measurement date and recognition period for such instruments. In general, the measurement date is (a) when a performance commitment, as defined, is reached or (b) when the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the ASC 505.

Income Taxes

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

Earnings Per Share

Basic income per common share is computed based upon the weighted average common shares outstanding as defined by FASB ASC No. 260, Earnings Per Share.

Diluted income per share includes the dilutive effects of stock options, convertible debt, warrants, and stock equivalents. To the extent stock options, stock equivalents and warrants are anti-dilutive; they are excluded from the calculation of diluted income per share. As of March 31, 2019, there were approximately 3,597,620 share equivalents for potential conversion demand of our outstanding convertible notes and warrants.

11

3. Restatement of financial statements

The following reflects changes to the accounts affected as a result of the restatement:
Changes to the Balance Sheet	As originally filed			As restated			Change Increase/ (decrease)
Accrued Interest	$	50,165		$	78,677		$	28,513
Convertible Notes Payable	$	273,709		$	506,412		$	232,703
Changes to Other Income and Expense
Interest Expense	$	31,541		$	31,972		$	431
Debt financing penalties	$	---		$	14,094		$	14,094
Gain on Settlement of Debt	$	246,691		$	-		$	(246,691	)
The following reflects changes to the balance sheet as a result of the restatement:
Liabilities and Stockholders’ Deficit
Current liabilities	As originally filed			As restated			Change Increase/ (decrease)
Accounts payable	$	17,500		$	17,500		$	-
Accrued interest		50,165			78,677			28,513
Accrued salaries and taxes		931,948			931,948			-
Due to principle shareholder, related party		10,795			10,795			-
Convertible notes payable		273,709			506,412			232,703
Total current liabilities		1,284,117			1,545,332			261,215
Stockholders’ Deficit
Preferred Stock, Series A $.0001 par value, 500,000 shares authorized; none issued and outstanding		50			50			-
Preferred Stock, Series B $.001 par value, 500,000 shares authorized; none issued and outstanding		-			-			-
Common Stock, $0.00001 par value, 199,000,000 shares authorized15,057,517 and 9,364 issued and outstanding, respectively		150			150			-
Common stock payable		-			-			-
Additional paid-in capital		25,038,765			25,038,765			-
Accumulated deficit		(26,569,799	)		(26,584,036	)		(261,215	)
Total stockholders’ deficit	$	(1,530,834	)	$	(1,545,071	)	$	(261,215	)
The following reflects changes to net income and loss per share as a result of the restatement:
	As originally filed			As restated			Change Increase/ (decrease)
Net income/(loss)	$	(2,936,188	)	$	(3,197,403	)	$	(261,215	)
Loss per share, basic and dilutive	$	(0.70	)	$	(0.41	)	$	0.29
Weighted average shares outstanding, basic and dilutive		4,221,826			7,784,185			3,597,620

12

4. Going Concern

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern.

The Company incurred net losses of $3,197,403 for the three months ended March 31, 2019 and had net cash used in operating activities of $11,696 for the same period. Additionally, the Company has an accumulated deficit of $26,584,036 and a working capital deficit of $1,545,071 at March 31, 2019. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of at least twelve months after the date of issuance on these financial statements. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to achieve a level of profitability and/or to obtain adequate financing through the issuance of debt or equity in order to finance its operations.

While the Company is attempting to commence operations and produce revenues, the Company’s cash position may not be significant enough to support the Company’s operations. While the Company believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. The key factors that are not within the Company’s control and that may have a direct bearing on operating results include, but are not limited to, acceptance of the Company’s business plan, the ability to raise capital in the future, the ability to expand its customer base, and the ability to hire key employees to build and maintain websites and to provide services and support to its customers and users. There may be other risks and circumstances that management may be unable to predict.

The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

5. Recently Issued Accounting Pronouncements

We have reviewed all FASB issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.

In July 2018, FASB issued Accounting Standards Update 2018-11; Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480): Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Non-public Entities and Certain Mandatorily Redeemable Non-controlling Interests with a Scope Exception. The guidance is intended to reduce the complexity associated with issuers’ accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, a down round feature (as defined) would no longer cause a freestanding equity-linked financial instrument (or an embedded conversion option) to be accounted for as a derivative liability at fair value with changes in fair value recognized in current earnings. The amendments in this ASU are effective for interim and annual periods beginning after December 15, 2018. Early adoption is permitted. We adopted Topic 718 effective January 1, 2019 and management believes that the standard will not have a significant effect on our results of operations or cash flows.

13

In May 2018, FASB issued Accounting Standards Update 2018-09; Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting. The amendments in this ASU amends the scope of modification accounting for share-based payment arrangements, provides guidance on the types of changes to the terms or conditions of share-based payment awards an entity is required to apply modification accounting under ASC 718. The amendments in this ASU are effective for interim and annual periods beginning after December 15, 2018. Early adoption is permitted. We adopted Topic 718 effective January 1, 2019 and management believes that the standard will not have a significant effect on our results of operations or cash flows.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This ASU is based on the principle that entities should recognize assets and liabilities arising from leases. The ASU does not significantly change the lessees’ recognition, measurement and presentation of expenses and cash flows from the previous accounting standard. Leases are classified as finance or operating. The ASU’s primary change is the requirement for entities to recognize a lease liability for payments and a right of use asset representing the right to use the leased asset during the term on operating lease arrangements. Lessees are permitted to make an accounting policy election to not recognize the asset and liability for leases with a term of twelve months or less. Lessors’ accounting under the ASC is largely unchanged from the previous accounting standard. In addition, the ASU expands the disclosure requirements of lease arrangements. Lessees and lessors will use a modified retrospective transition approach, which includes a number of practical expedients. The effective date will be the first quarter of fiscal year 2020 with early adoption permitted. We adopted Topic 842 effective January 1, 2019 and management believes that the standard will not have a significant effect on our results of operations or cash flows.

6. Related Party Transactions

The majority shareholder has advanced funds since inception, for the purpose of financing working capital and product development. As of March 31, 2019 and 2018, the Company owed $10,795 and $0, respectively. There are no repayment terms to these advances and deferrals and the Company has imputed interest at a nominal rate of 3%.

The Company has minimal needs for facilities and operates from office space provided by the majority shareholder. There are no lease terms. For the three months ended March 31, 2019 and 2018, rent has been calculated based on the limited needs at a fair market value of the space provided. Rent expense was $300 and $300 for the three months ended March 31, 2019 and 2018, respectively. The rental value has been recognized as an operating expense and treated as a contribution to capital.

The amounts and terms of the above transactions may not necessarily be indicative of the amounts and terms that would have been incurred had comparable transactions been entered into with independent third parties.

On March 31, 2019, the Company’s Board of Directors authorized the issuance of 15,000,000 shares to the Company’s Chief Executive Officer as a performance bonus pursuant to his employment agreement. The shares were valued at $0.20, the quoted market price on the date of issuance, or $3,000,000.

On March 1, 2018, the Company issued 45 shares of the Company’s Series A Preferred Shares to its sole director and chief executive officer in satisfaction of accrued compensation owed to him by the Company. (See Note 11).

On January 23, 2018, the Company issued 10,000 shares of its common stock to sole officer and director, Robert DeAngelis, as his 2017 annual bonus per his employment agreement. The annual bonus, if any, is determined and paid in accordance with policies set from time to time by the Board or Directors, in its sole discretion. The Board’s policy has been to base the stock price for such issuances upon the average of the closing price of the preceding 10 trading days as reported on OTC Markets website, which was $33.00; rendering the value of the preferred issued as $330,000. Since the Company’s closing stock price on the date of grant was also $33.00, the Company did not recognize any associated discounts or benefits associated with the shares issued.

On March 4, 2019, the Company renewed its three-year employment agreement with Robert DeAngelis to serve as the President and Chief Executive Officer of the Company. The employment agreement automatically renews for an additional twelve months upon expiration of each term. The agreement can be cancelled upon written notice by either employee or employer (if certain employee acts of misconduct are committed). The total minimum aggregate annual amount due under the employment agreement is $120,000 plus bonuses. For the three months ended March 31, 2019 and 2018, the Company recorded compensation expense in the amount of $30,000 and $30,000, respectively.

14

7. Accrued Liabilities

Accounts Payable and Accrued expenses:
	March 31, 2019		December 31, 2018
Accounts payable	$	17,500	$	3,000
Accrued interest		78,677		54,119
Accrued salaries, payroll taxes, penalties and interest (a)		931,948		807,108
Due to principle shareholder, related party		10,795		---

(a) The Company has accrued additional compensation to its Chief Executive Officer totaling $30,000 and $30,000 during the three months ended March 31, 2019 and 2018, respectively. However, the Company has not paid the related payroll taxes, consisting primarily of Social Security and Medicare taxes. As a result, the Company has established an accrued liability for the unpaid salaries, along with related taxes and estimated interest and penalties of $931,948 and $807,108 at March 31, 2019 and December 31, 2018, respectively.

8. Convertible Notes Payable

During the three months ended March 31, 2019 and 2018, respectively, the Company had convertible notes payable outstanding in which the conversion rate was variable and undeterminable. The Company determined that there wasn’t an active market for the Company’s common stock and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with these convertible notes as of March 31, 2019 and March 31, 2018. The Company uses judgment in determining the fair value of derivative liabilities at the date of issuance and at every balance sheet thereafter and in determining which valuation method is most appropriate for the instrument, the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate, if any.

As of March 31, 2019, all of the Company’s convertible promissory notes remain outstanding beyond their respective maturity dates; triggering an event of technical default under the respective agreements. Consequently, the Company is accruing interest on these notes at their respective default rates. As a result of being in default on these notes, the Holders could, at their sole discretion, call these Notes in their entirety, including all associated penalties provided for under the respective agreements. In this event, the Company may not have sufficient authorized shares to absolve itself of the defaulted Notes through the issuance of common shares of the Company. The Company is working with the current note holders and its transfer agent in order that it may resolve these outstanding issues as soon as practicable. On November 2, 2018, the Company received a formal letter from one of its Note Holders demanding payment of all amounts due under the Note plus applicable collection costs, including attorney’s fees at the Mandatory Default Amount. The varied terms and definitions of these default provisions are disclosed below in each of the respective Note disclosures.

As of March 31, 2019, the Company owed an aggregate of $585,089 in principal and accrued interest; of which, $506,412 (before a discount of $-0-) represents convertible notes payable and $78,677 represents accrued interest. At December 31, 2018, the Company owed an aggregate of $542,942 (before a discount of $4,915) in principal and accrued interest; of which, $493,738 represents convertible notes payable and $54,119 represents accrued interest.

	March 31, 2019		December31, 2018
Convertible promissory notes, various lending institutions, maturing at variable dates ranging from 180 days to one year from origination date, 8-10% interest and in default interest of 12-24%, convertible at discount to trading price (25-50%) based on various measurements of prior trading, at face value of remaining original note principal balance plus default penalties, net of unamortized debt discounts, attributable to derivative liabilities, and deferred financing costs in the amount of $-0- and $6,974, respectively.	$	506,412	$	493,738
Principal		506,412		493,738
Debt discount		---		(4,915	)
Total Principal	$	506,412	$	488,823

15

Summary of Convertible Note Transactions:
	March 31, 2019			December31, 2018
Convertible notes, January 1	$	493,738		$	364,721
Additional notes, face value		-			65,000
Default Penalties		14,094			172,886
Settlement of debt		-			(20,000	)
Conversions of debt		(1,420	)		(88,869	)
Unamortized debt discounts		-			(4,915	)
Convertible notes, balance	$	506,412		$	488,823

Note 6. On October 6, 2017, the Company entered into a Convertible Promissory Note with an accredited investor pursuant to which the Company received $150,000 in financing and an initial tranche of $20,000. Each tranche paid under the Note matures in 12 months and is convertible into shares of the Company’s common stock after a period of six months at a conversion price equal to 50% of the lowest trading price per share during the previous ten (10) trading days. The Company evaluated the terms of the convertible note in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock and determined that the underlying is indexed to the Company’s common stock. The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. During the year ended December 31, 2018, the Company determined that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note. On May 9, 2018, the note holder agreed to forgive the balance of the principal and accrued interest. As a result, during the year ended December 31, 2018, the Company has recognized a gain on the extinguishment of debt in the amount of $20,589 and canceled the reserve of 50,000 shares of common stock.

Note 5. On October 2, 2017, the Company received $53,000 in financing through the execution of a Convertible Promissory Note associated with a Securities Purchase Agreement. The Note bears interest at a rate of 12% and matures 280 days from the purchase date. The Note is convertible into shares of the Company’s common stock after a period of 180 days at a conversion price equal to 61% multiplied by the average of the lowest two trading prices during the previous fifteen (15) days. After 180 days following the Issue Date, the Company will have no right of prepayment. The Company evaluated the terms of the convertible note in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock and determined that the underlying is indexed to the Company’s common stock. The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. During the year ended December 31, 2018, the Company determined that there was no active market for the Company’s common stock. and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note. In addition, the Company issued an aggregate of 15,813 common shares in satisfaction of $53,000 in principal and $3,727 in accrued interest. As of December 31, 2018, the note was considered paid in full and the Company canceled the reserve of 41,945 shares of common stock.

Note 4. On July 8, 2017, the Company’s Board of Directors approved the assignment of a convertible note payable to a different third-party. The total amount assigned was $27,846 which includes principal of $20,775 and accrued interest of $7,087. The terms of the original February 20, 2015 Convertible Promissory Note remain in effect and the note continues to accrue interest at a rate of 8% per annum until the note is paid in full. In connection with the assignment, the Company issued 335 common shares for a value of $3,350, which was applied against the balance of accrued interest on the note. During the year ended December 31, 2018, the Company issued an aggregate of 1,125 common shares in satisfaction of $10,696 in principal and $554 in accrued interest for a total value of $11,250 and canceled the reserve of 49 shares of common stock. As of December 31, 2018, the note was considered paid in full.

Note 3. On July 5, 2017, the Company entered into a Securities Purchase Agreement and related documents with an institutional accredited investor. On the Closing Date, the Company issued a Convertible Promissory Note in the principal amount of $175,000 in exchange for payment by Investor of $157,500. The principal sum of the Note reflects the amount invested, plus a $17,500 “Original Issue Discount” and accrues interest at 5% per annum. The Holder has the right at any time to convert all or any part of unpaid principal and interest into common shares of the Company equal to 50% multiplied by the Market Price; that being the lowest (1) trading price for the common stock during the twenty-five trading days prior to the conversion date, subject to anti-dilution and market adjustments set forth in the Agreement.

In connection with the Financing, and in addition to the Securities Purchase Agreement and the Secured Convertible Promissory Note, the Company issued a Warrant which grants the investor the right to purchase at any time on or after each tranche, and for a period of five years thereafter, a number of fully paid and non-assessable shares of the Company’s common stock equal to the amount of each tranche received under the Note divided by $0.05. (See Note 9) On April 30, 2018, the Company’s Board of Directors approved the assignment of the Note to a different third-party. The total amount assigned was $30,306 which includes principal of $28,959 and accrued interest of $1,347. Subsequent to the assignment, the Company received additional tranches from the Assignee in the aggregate amount of $65,000 with no associated discounts. The Warrant associated with the Securities Purchase Agreement was not included in the Assignment of the Original Note.

16

The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. For the three months ended December 31, 2018, the Company concluded that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note.

The Note became due and payable on July 5, 2018 and the Company had defaulted on its obligations under the Note. Interest on the Note was then accrued at the default rate of 24% per annum and the Company classified the Note as a current liability. The Company is required to have authorized and reserved three and ten (10) times the number of shares that is actually issuable upon full exercise of the Note. The Note Holder could, at the Holder’s sole discretion, call the Note and impose the related default penalties. In this event, the Company would be obligated to pay 150% multiplied by the then outstanding entire balance and the Company would then also be in technical default of its Reserve requirement as it would have insufficient common shares authorized to cover the aggregate reserve requirement of all notes in default. As of March 31, 2019, the equivalent number of shares the Company would be required to issue to satisfy the Note is 316,880 and the Company is in technical default of the Reserve share requirement which is allocable between the Note and the detached Warrant (See Note 9).

During the three months ended March 31, 2019, no shares were issued against the note. As a result of the Company’s stock split effective March 1, 2019, the Company incurred a default penalty in the amount of $14, 094 and this was applied to the principal balance of the Note. During the year ended December 31, 2018, the Company issued an aggregate of 467 common shares in satisfaction of $6,041 in principal and fees under the Note of $500.

Note 2. On May 5, 2017, the Company entered into a Securities Purchase Agreement (“SPA”) with an institutional accredited investor pursuant to which the Company received $165,000 in financing through the execution of a Convertible Promissory Note. In addition, the Company issued 115 shares of common stock for a value of $63,415 as consideration for entering into the financing agreement. The Note matures in 10 months and is convertible into shares of the Company’s common stock at a conversion price equal to 50% of the lowest trading price per share during the previous twenty-five (25) trading days, subject to anti-dilution and market adjustments set forth in the Agreement.

The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. For the three months ended March 31, 2019 and 2018, the Company concluded that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note. The Company recognized a debt discount on the note as a reduction (contra-liability) to the Convertible Note Payable and is being amortized over the life of the note.

During the year ended December 31, 2018, the Company was required to increase the principal balance of the note by $5,000 pursuant to Section 1.3 of the Agreement which states that if the Borrower does not maintain or replenish the Reserved Amount within three (3) business days of the request of the Holder, the principal amount will increase by $5,000 for each such occurrence. In addition, under Section 1.4(g) of the Note, the Company was required to increase the principal amount of the Note by $15,000 due to the conversion price being less than $0.01. The penalties are tacked back to the Issue Date of the Note.

The Note became due and payable on February 5, 2018 and the Company remains in default of its obligations under the Note. Interest on the Note is being accrued at the default rate of 12% per annum and the Company classified the Note as a current liability. The Company is required to have authorized and reserved three and one half (3.5) times the number of shares that is actually issuable upon full exercise of the Note. On February 5, 2018, the Company was obligated to pay a Default Sum calculated as 150% multiplied by the then outstanding entire balance and recorded a penalty in the amount of $92,886 for failing to pay at maturity. As of March 31, 2019, the equivalent number of common shares the Company would be required to issue to satisfy the Note is 1,618,558.

During the three months ended March 31, 2019, the Company issued 4,900 common shares for a value of $3,920, satisfying $1,420 in principal, $1,500 in accrued interest, and $1,000 in finance costs. As of March 31, 2019, the Company owed $160,823 in principle, $112,886 in default penalties and accrued interest of $50,003. During the year ended December 31, 2018, the Company issued 3,300 common shares for a value of $6,480, satisfying $5,480 in principal and $1,000 in finance costs. As of December 31, 2018, the Company owed $275,129 in principle and accrued interest of $35,292.

Note 1. On March 13, 2017, the Company entered into an Agreement with an institutional Lender. On that date, the Company issued to the Lender a Secured Convertible Promissory Note in the principal amount of $230,000; of which, the Company has received $150,000 as of December 31, 2018. The principal sum of the Note reflects the amount borrowed, plus a $20,000 “Original Issue Discount” and a $10,000 reimbursement of Lender’s legal fees. On July 6, 2018, the Company’s Board of Directors approved the assignment of this Convertible Promissory Note to a different third-party. The terms of the original March 13, 2017 Convertible Promissory Note remain in effect and the note continues to accrue interest at a rate of 10% per annum until the note is paid in full.

17

In connection with the Financing, and in addition to the Securities Purchase Agreement and the Secured Convertible Promissory Note, the Company issued a Warrant which grants the right to purchase at any time on or after March 13, 2017 and for a period of three years, a number of fully paid and non-assessable shares of the Company’s common stock equal to $57,500 divided by the Market Price as of the issue date. (See Note 9) Effective on July 20, 2018, the Warrant to Purchase Shares previously issued under the March 13, 2017 Convertible Promissory Note was terminated by the Warrant holder to facilitate the Company’s fundraising efforts.

The Secured Convertible Promissory Note matures in 10 months and is convertible into shares of the Company’s common stock at a conversion price equal to $0.25 per share. In the event the minimum market capitalization falls below $6,000,000, then the conversion price is the lesser of the stated price of $0.25 or the market price (as calculated pursuant to the Agreement). Pursuant to the terms of the SPA and the Note, the Company is required to reserve and keep available out of its authorized and unissued shares of common stock a number of shares of common stock at least equal to three (3) times the number of shares issuable on conversion of the Note.

The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. For the three months ended March 31, 2019 and 2018, the Company determined that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note. The Company recognized a debt discount on the notes as a reduction (contra-liability) to the Convertible Notes Payable and the discounts are being amortized over the life of the notes.

The Note became due and payable on January 13, 2018 and the Company is in default of its obligations under the Note. Interest on the Note is being accrued at the default rate of 22% per annum beginning on July 6, 2018 and the Company classified the Note as a current liability. On November 2, 2018, the Note Holder demanded payment of all amounts due under the Note plus applicable collection costs, including attorney’s fees at the Mandatory Default Amount. The Mandatory Default Amount means the greater of (a) the Outstanding Balance divided by the Installment Conversion Price on the date the Mandatory Default Amount is demanded, multiplied by the VWAP on the date the Mandatory Default Amount is demanded, or (b) the Outstanding Balance following the application of the Default Effect. Pursuant to the demand letter on that date, the Company owed $125,053, which includes the mandatory default amount and interest will continue to accrue at the rate of $78.80 per day. The principal increase is considered applied as of the date of the demand for payment and is not tacked back to the Issue Date of the Note.

Pursuant to the terms of the SPA and the Note, the Company is required to reserve and keep available out of its authorized and unissued shares of common stock a number of shares of common stock at least equal to three (3) times the number of shares issuable on conversion of the Note. The Company will have insufficient common shares authorized to cover the aggregate reserve requirement of all notes in default. As of March 31, 2019, the Company owed $124,650 in principal, $18,528 in interest, and the equivalent number of shares the Company would be required to issue to satisfy the Note is 572,712. As of December 31, 2018, the Company owed $124,650 in principal and accrued interest of $11,766.

9. Warrant Liabilities

The Company estimates the fair value of each option award on the date of grant using the Binomial option valuation model that uses the assumptions noted in the table below. Because Binomial option valuation models incorporate ranges of assumptions for inputs, those ranges are disclosed. Expected volatilities are based on the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from certain groups of employees exhibiting different behavior. During the year ended December 31, 2018, management determined that the Company’s common stock lacked liquidity and market value and therefore no derivative liability was recorded in association with these warrants.

The following table sets forth common share purchase warrants outstanding as of March 31, 2019:

	March 31, 2019		December 31, 2018
Warrants, January 1		66		122
Additions		---		---
Conversions		---		(4	)
Forfeitures		---		(52	)
Warrants, balance		66		66

18

			Weighted
			Average
			Exercise		Intrinsic
	Warrants		Price		Value
Outstanding, January 1		66	$	7.74	$	7.66
Warrants granted and issued		---	$	---	$	---
Warrants forfeited		---	$	---	$	---
Outstanding, March 31		66	$	7.74	$	7.66
Common stock issuable upon exercise of warrants		984,714	$	0.0034	$	0.80

Warrants Outstanding								Warrants Exercisable
				Weighted
		Number		Average		Weighted		Number		Weighted
		Outstanding		Remaining		Average		Exercisable		Average
Exercise		at March 31,		Contractual		Exercise		at March 31,		Exercise
Price		2019		Life (Years)		Price		2019		Price
$	0.20		66		0.65	$	0.0034		66	$	0.0034

The warrants convert at a rate of $0.20 per warrant, based on anti-dilution adjustments to the exercise price.

On July 5, 2017, the Company entered into a Securities Purchase Agreement and related documents with an institutional accredited investor. On the Closing Date, the Company issued to Investor a Convertible Promissory Note in the principal amount of $175,000 in exchange for payment by Investor of $157,500. In connection with the Financing, and in addition to the Securities Purchase Agreement and the Secured Convertible Promissory Note, the Company issued a Warrant (“Warrant 1”) which grants the investor the right to purchase at any time on or after each tranche, and for a period of five years thereafter, a number of fully paid and non-assessable shares of the Company’s common stock equal to the amount of each tranche received under the Note divided by $0.05, as adjusted from time to time pursuant to the terms and conditions of the Warrant. The conversion option and the outstanding common stock warrants on that date are classified as derivative liabilities at their fair value on the date of issuance. During the year ended December 31, 2017, the Company received a tranche of $35,000; resulting in the issuance of a warrant to purchase 70 shares of the Company’s common stock at $5,000 per share, resulting in an exercise value at issuance of $350,000. The relative fair value of the warrant at issuance was $12,565, which was recorded as a debt discount and amortized over the life of the note.

The Company estimates the fair value at each reporting period using the Binomial Method. During the year ended December 31, 2018, management determined that the Company’s common stock lacked liquidity and market value and therefore no derivative liability was recorded in association with these warrants and in quarter ending March 31, 2018, the Company recorded a gain on the write-off of the fair value of the warrant in the amount of $35,047.

The Warrant may be exercised in whole or in part at $5,000 per share, subject to anti-dilution adjustments set forth in the Agreement. If the Market Price is greater than the Exercise Price, the Warrant Holder may elect to receive Warrant shares pursuant to a cashless exercise. The Market Price means the highest traded price of the Company’s common stock during the twenty (20) trading days prior to the date of the respective Exercise Notice. A dilutive issuance occurs when the Company issues common stock at an effective price per share that is less than the then-current Exercise Price. In this event, the Exercise Price is adjusted to match the lowest price per share at which such Common Stock was issued or may be acquired in the dilutive issuance.

The Company is required to reserve and keep available out of its authorized and unissued shares of common stock a number of shares of common stock equal to five (5) times the number of shares issuable on conversion of the Warrant. As of March 31, 2019, the Company is in technical default of its Reserve requirement for the detached Warrant.

During the three months ended March 31, 2019, no warrants were exercised. The warrant derivative liability as of March 31, 2019 and December 31, 2018 was $0 and $0, respectively. As of March 31, 2019, the remaining equivalent number of shares the Company would be required to issue under a cashless exercise of the Warrant is estimated to be 984,714 shares, which is based upon an exercise price of $0.20.

19

On March 13, 2017, the Company entered into an Agreement with an institutional Lender. On that date, the Company issued to the Lender a Secured Convertible Promissory Note in the principal amount of $230,000; of which, the Company has received $150,000 as of December 31, 2017. In connection with the Financing, and in addition to the Securities Purchase Agreement and the Secured Convertible Promissory Note, the Company issued a Warrant (“Warrant 2”) which grants the right to purchase at any time on or after March 13, 2017 and for a period of three years, a number of fully paid and non-assessable shares of the Company’s common stock equal to $57,500 divided by the Market Price as of the issue date. The Market Price is the conversion factor multiplied by the average of the three lowest closing bid prices during the twenty trading days immediately preceding the applicable conversion. If the average of the three lowest closing bid prices is below $0.10, then the conversion factor is permanently reduced by 10%. If at any time the Company is not DTC eligible, then the conversion factor is further reduced by an additional 5%. At any time prior to the expiration date, the investor may elect a cashless exercise for any warrant shares equal to (i) the excess of the Current Market Value (Trade Price times the number of exercise shares) over the aggregate Exercise Price of the Exercise Shares, divided by (ii) the Adjusted Price (the lower of the Exercise Price of $0.25 or Market Price). The Trade Price is the higher of the closing trade price on the issue date or the VWAP of the stock for the trading day that is two trading days prior to exercise date. The conversion option and the outstanding common stock warrants on that date are classified as derivative liabilities at their fair value on the date of issuance. Under ASC-815 the conversion options embedded in notes payable require liability classification because the note does not contain an explicit limit to the number of shares that could be issued upon settlement.

The Market Price, as calculated pursuant to the Warrant Agreement, was $1,097 per share with 52 being the resulting number of warrant shares at issuance. The relative fair value of the warrant at issuance was $0, resulting in no debt discount. The Company estimates the fair value at each reporting period using the Binomial Method. As of March 31, 2018, management determined that the Company’s common stock lacked liquidity and market value and therefore no derivative liability was recorded in association with these warrants. As a result, the Company recorded a gain on the write-off of the fair value of the warrant in the amount of $2,779. The warrant derivative liability as of March 31, 2019 and March 31, 2018 was $0 and $0, respectively. Effective July 20, 2018, the warrant to purchase shares previously issued under the Convertible Promissory Note was terminated by the Warrant holder to facilitate the Company’s fundraising efforts.

The following table indicates the fair value of the warrants recorded by the Company at issuance.

	Amount		Factor		Warrant Shares		Stock Price on Date of Grant		Fair Value at Issuance		Fair Value as of December 31, 2017
Warrant 1	$	35,000	$	500		70	$	300	$	12,565	$	32,268
Warrant 2	$	57,500	$	1,097		52	$	900	$ -0-		$	2,779
Total	$	92,500				122			$	12,565	$	35,047

10. Derivatives and Fair Value

The Company evaluated the terms of the convertible notes, in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock and determined that the underlying is indexed to the Company’s common stock. The Company determined that the conversion features meet the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. The Company evaluated the conversion feature for the embedded conversion option. Since these notes contain conversion price adjustment provisions (i.e. down round, or ratchet provisions), the Company determined that the embedded conversion options met the definition of a derivative. The effective conversion price was compared to the market price on the date of the note and was deemed to be less than the market value of underlying common stock at the inception of the note. The Company recognized a debt discount on the notes as a reduction (contra-liability) to the Convertible Notes Payable. The debt discounts are being amortized over the life of the notes. The Company recognized financing costs for charges by the lender for original issue discounts and other applicable administrative costs, normally withheld from proceeds, which are being amortized as finance costs over the life of the loan. The derivative values are calculated using the Binomial method.

As of March 31, 2019 and December 31, 2018, the Company had convertible notes payable outstanding in which the conversion rate was variable and undeterminable; however, the Company determined that there was no active market for the Company’s common stock and because of this lack of liquidity and market value, there was no derivative liability associated with the convertible notes. The Company uses judgment in determining the fair value of derivative liabilities at the date of issuance and at every balance sheet thereafter and in determining which valuation method is most appropriate for the instrument, the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate, if any.

ASC 825-10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 825-10 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 describes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities; Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. The Company’s Level 3 liabilities consist of the derivative

liabilities associated with the convertible notes. At March 31, 2019 and December 31, 2018, all of the Company’s derivative liabilities were categorized as Level 3 fair value liabilities. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

20

Level 3 Valuation Techniques

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. At the date of the original transaction, we valued the convertible note that contains down round provisions using a Black-Scholes model, with the assistance of a valuation consultant, for which management understands the methodologies. This model incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior. Using assumptions, consistent with the original valuation, the Company has subsequently used the Binomial model for calculating the fair value.

11. Equity

Stock Compensation

On March 31, 2019, the Company’s Board of Directors authorized the issuance of 15,000,000 shares to the Company’s Chief Executive Officer as a performance bonus pursuant to his employment agreement. The shares were valued at $0.20, the quoted market price on the date of issuance, or $3,000,000.

On March 1, 2018, the Company issued449,065 shares of the Company’s Series A Preferred Shares to its sole director and chief executive officer for a value of $112,266, or $2,500 per share. The value was recorded against his accrued compensation payable.

On January 23, 2018, the Company issued 1,000 shares of its common stock to sole officer and director, Robert DeAngelis, as his 2017 annual bonus per his employment agreement. The annual bonus, if any, is determined and paid in accordance with policies set from time to time by the Board or Directors, in its sole discretion. The Board’s policy has been to base the stock price for such issuances upon the average of the closing price of the preceding 10 trading days as reported on OTC Markets website, which was $33.00; rendering the value of the preferred issued as $330,000. Since the Company’s closing stock price on the date of grant was also $33.00, the Company will not recognize any associated discounts or benefits associated with the shares issued.

Stock Issued for Debt and Interest

During the year ended December 31, 2018, the Company issued 31,745 shares of common stock, for a value of $86,811 in satisfaction of $37,101 principal, $39,710 accrued interest, and $10,000 in conversion fees on its convertible notes payable. The Company recorded the issuances at the contract value, at the date of exchange, off-setting the notes payable and accrued interest.

Preferred Stock

On March 1, 2018, the Company issued 45 shares of the Company’s non-convertible Series A Preferred Shares, with a par value of $0.0001 and with an initial liquidation preference of $200 per share pursuant to its amended and restated Articles on July 26, 2016, at a price of $200 per share, to its sole director and chief executive officer in exchange for $112,266 of accrued compensation. The Company valued the transaction at $8981 and recognized the difference in fair value to additional paid in capital.

Warrants

On the July 10, 2017, and in connection with a Securities Purchase Agreement and a Secured Convertible Promissory Note, the Company issued a Warrant which grants the investor the right to purchase at any time on or after July 10, 2017, and for a period of five years thereafter, a number of fully paid and non-assessable shares of the Company’s common stock equal to the amount of the tranche received under the Note divided by $500. The conversion price is $0.50, as adjusted from time to time pursuant to the terms and conditions of the Warrant. As of December 31, 2017, the Company received a tranche of $35,000; resulting in the issuance of a warrant to purchase 70 shares of the Company’s common stock. The relative fair value of the warrant at issuance was $12,565. The Company estimates the fair value at each reporting period using the Binomial Method. For the three months ended March 31, 2019, management determined that the Company’s common stock lacked liquidity and market value and therefore no derivative liability was recorded in association with these warrants. The warrant derivative liability as of March 31, 2019 and 2018 was $0 and $0, respectively. During year ended December 31, 2018, the Warrant Holder, in a cashless exercise, was issued 6,032 shares of common stock for an aggregate value of $9,456 pursuant to anti-dilution terms of the Warrant that adjusted the conversion price.

On the March 13, 2017, and in connection with a Securities Purchase Agreement and a Secured Convertible Promissory Note, the Company issued a Warrant which grants the investor the right to purchase at any time on or after March 13, 2017, and for a period of three years thereafter, a number of fully paid and non-assessable shares of the Company’s common stock equal to $57,500 divided by the Market Price as of March 13, 2017. The Market Price, as calculated pursuant to the Warrant Agreement, was $1,097 per share with 52 being the resulting number of warrant shares at issuance. The relative fair value of the warrant at issuance was $47,174, resulting in a debt discount equal to $10,326 which will be amortized over the life of the Warrant. The Company estimates the fair value at each reporting period using the Binomial Method. The warrant derivative liability as of March 31, 2019 and 2018 was $0 and $0, respectively. Made effective on July 20, 2018, the warrant to purchase shares previously issued under the Convertible Promissory Note was terminated by the Warrant holder to facilitate the Company’s fundraising efforts.

21

Other

During the three months ended March 31, 2019 and 2018, the Company recorded in-kind contributions for rent expense in the amount of $300 and $300, respectively.

Amendment to the Articles of Incorporation

Pursuant to a written consent in lieu of a meeting, dated January 21, 2019, the Board approved to amend our Articles of Incorporation to (i) effect a 1-for-10,000 reverse stock split of our issued and outstanding shares of Common Stock, par value $0.00001 per share, and (ii) decrease the amount of authorized shares of Common Stock from 9.999 billion (9,999,000,000) prior to the Reverse Stock Split to 200 million (200,000,000). The Company has retro-actively applied the reverse stock split made effective on March 1, 2019 to these financial statements. 

As of March 31, 2019, the total number of shares this corporation is authorized to issue is 200,000,000 (two-hundred million), allocated as follows among these classes and series of stock:

Designation	Par value		Shares Authorized
Common	$	0.00001		200,000,000
Preferred Stock Class, Series A	$	0.0001		500,000
Preferred Stock Class, Series B	$	0.0001		500,000

On February 20, 2018, the Board of Directors recommended and the majority shareholder (holding 83% of the voting shares) voted in favor of increasing the authorized capital of the Company from Three Billion (3,000,000,000) shares, to Ten Billion (10,000,000,000) shares. No change was made to the number of preferred shares authorized. Accordingly, as of February 20, 2018, the total authorized capital of the Company will be comprised of Nine Billion Nine Hundred Ninety-Nine Million (9,999,000,000) shares of common stock, par value $0.00001 per share, and One Million (1,000,000) shares of Preferred Stock, of which Five Hundred Thousand (500,000) shares are designated as Series A Preferred Stock, par value $0.0001 per share.

On February 5, 2018, the Board of Directors recommended and the majority shareholder (holding 74% of the voting shares) voted in favor of increasing the authorized capital of the Company from One Billion (1,000,000,000) shares, to Three Billion (3,000,000,000) shares. No change was made to the number of preferred shares authorized. Accordingly, as of February 5, 2018, the total authorized capital of the Company will be comprised of Two Billion Nine Hundred Ninety-Nine Million (2,999,000,000) shares of common stock, par value $0.00001 per share, and One Million (1,000,000) shares of Preferred Stock, of which Five Hundred Thousand (500,000) shares are designated as Series A Preferred Stock, par value $0.0001 per share.

12. Commitments and Contingencies

From time to time the Company may be a party to litigation matters involving claims against the Company. Management believes that there are no known or potential matters that would have a material effect on the Company’s financial position or results of operations.

The Company’s operations are subject to significant risks and uncertainties including financial, operational and regulatory risks, including the potential risk of business failure.

There were no operating or capital lease commitments as of March 31, 2019 and March 31, 2018.

13. Subsequent Events

The Company has evaluated all events that occur after the balance sheet date through the date when the financial statements were issued to determine if they must be reported.

On April 10, 2019, the Company entered into a Joint Venture Agreement with a third party for purposes of building a digital platform for real estate transactions. The parties have agreed that any projects undertaken jointly from which any funds are raised through the joint venture shall be split 50% to the Company and 50% to the third party. For and in consideration of the services to be provided, the Company has issued 1,250,000 shares of common stock. The shares were valued at $0.55, the quoted market price on the date of issuance, or $687,500.

On April 10, 2019, the Company entered into a Consulting Agreement with a third party for purposes of establishing real estate management and real estate holding divisions. The Company has agreed to dedicate a minimum of thirty-three percent (33%) of all funds received by the Company to the new division. The term of the Agreement is for a period of twelve months and is automatically extended for successive three month terms. For and in consideration of the services to be provided, the Company has issued 1,250,000 shares of common stock. The shares were valued at $0.55, the quoted market price on the date of issuance, or $687,500.

22

On December 20, 2019, the Company entered into a securities purchase agreement with Auctus Fund, LLC, a Delaware limited liability company. The SPA provides for the purchase by Actus of a senior secured convertible promissory note in the principal amount of $1,100,000 and a warrant to purchase common stock issued by the Company. On January 15, 2020, the Company authorized the disbursement of the proceeds of this $1,100,000 Note to Florida Beauty Flora, Inc.. The Promissory Note matures on December 20, 2020 and bears interest at a rate of 12% per annum.

On December 26, 2019, we entered into a definitive agreement and plan of merger and reorganization with Florida Beauty Express Inc., Florida Beauty Flora Inc., Floral Logistics of Miami Inc., Floral Logistics of California Inc. and Tempest Transportation Inc. (collectively “Florida Beauty”), pursuant to which Florida Beauty may purchase all of the shares of stock of our Company held by Robert DeAngelis, our sole director and officer.

In December 2019, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries, including the United States, and infections have been reported globally.

The COVID-19 outbreak is a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could materially impact our efforts to effectuate ordinary business transactions into the unforeseeable future. A pandemic typically results in social distancing, travel bans and quarantine, and this may limit access to our facilities, customers, management, support staff and professional advisors. These factors, in turn, may not only impact our operations, financial condition and demand for our goods and services but our overall ability to react timely to mitigate the impact of this event. In addition, it may hamper our efforts to comply with our filing obligations with the Securities and Exchange Commission.

Our business has been disrupted, but the extent to which the coronavirus impacts our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact. International stock markets have begun to reflect the uncertainty associated with the slow-down in the American, European, and Asian economies, and the significant decline in the Dow Industrial Average in February and March 2020, was largely attributed to the effects of COVID-19.

On January 7, 2020, 100,000 shares of the Company’s common stock were issued to its President and Chief Executive Officer pursuant to the Plan of Share Exchange Agreement originally entered into on December 27, 2019 with Florida Beauty Express, Inc., Florida Beauty Flora, Inc., Floral Logistics of Miami, Inc., Floral Logistics of California, Inc., and Tempest Transportation Inc.

On January 13, 2020, we entered into an Amended Agreement and Plan of Share Exchange Agreement (the “Agreement”) by and Amongst, REAC Group, Inc. (“REAC”) and Florida Beauty Express, Inc., Florida Beauty Flora, Inc., Floral Logistics of Miami, Inc., Floral Logistics of California, Inc., Tempest Transportation Inc. (the “Companies”). The Agreement is for the exchange of 100% of the outstanding shares of the Companies in exchange for 15,015,002 shares of REAC Common Stock and 500,000 shares of REAC Series A Preferred Stock. The Agreement also states that the Mr. Robert DeAngelis will return to the REAC Treasury all of the shares that he currently controls, in return for $350,000, to be paid as follows: $100,000 shall be paid in cash within three (3) days of closing by wired funds to Robert DeAngelis, (the “Closing Cash”), and the remaining $150,000 will be payable in $75,000 installments for the first two quarters after closing (March 31, 2020 and June 30, 2020 respectively) and Mr. DeAngelis will also receive 100,000 shares of common stock, that will be valued at $1.00 per share, respectively. As part of the Agreement, Mr. Robert DeAngelis will also resign and appoint new officers and directors as to be chosen by the Companies.

On February 3, 2020, the Company entered into a Senior Convertible Promissory Note in the amount of $277,750 and the Company authorized the disbursement of the proceeds to Florida Beauty Flora, Inc. The Note bears interest at a rate of 12% and matures one year from the purchase date. The Note is convertible into shares of the Company’s common stock at a conversion price equal to 50% multiplied by the lowest trading price during the previous twenty-five (25) days. At any time during the period beginning on the Issue Date and ending on the last Trading Day immediately preceding the Maturity Date, the Borrower shall have the right, exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note and subject to the Holder’s written consent at the time of such prepayment, to prepay the outstanding Note (principal and accrued interest), in full by making a payment to the Holder of an amount in cash equal to 150%, multiplied by the sum of the then outstanding principal amount of this Note, plus accrued and unpaid interest on the unpaid principal amount of the Note, plus Default Interest, if any.

On February 14, 2020, the Company issued 500,000 shares of common stock to its President and Chief Executive Officer as a performance bonus for the year ending December 31, 2019. The shares were valued at the quoted market price on the date of issuance.

23

On February 25, 2020, the Company issued 1,000,000 shares of common stock to its President and Chief Executive Officer as a performance bonus for 2020. The shares were valued at the quoted market price on the date of issuance.

On April 13, 2020, we entered into a second Amended Agreement and Plan of Share Exchange Agreement that was originally entered into on December 26, 2019 (the “Agreement”) by and Amongst, REAC Group, Inc. (“REAC”) and Florida Beauty Express, Inc., Florida Beauty Flora, Inc., Floral Logistics of Miami, Inc., Floral Logistics of California, Inc., Tempest Transportation Inc. (the “Companies”) and Companies shareholders. The Agreement is for the exchange of 100% of the outstanding shares of the Companies in exchange for 15,015,002 shares of REAC Common Stock and 500,000 shares of REAC Series A Preferred Stock. The Conditions to the Agreement have been satisfied and fully closed, and the Companies are now wholly-owned subsidiaries of REAC. The Agreement also states that Mr. Robert DeAngelis will return to the REAC Treasury all of the shares that he currently controls, in return for $350,000, to be paid as follows: $100,000 shall be paid in cash within three (3) days of closing by wired funds to Robert DeAngelis, (the “Closing Cash”), the Closing Cash has been paid, and the remaining $150,000 will be payable in $75,000 installments for the first two quarters after closing (April 30, 2020 (of which $12,000 has been paid) and June 30, 2020 respectively) and Mr. DeAngelis will also receive 100,000 shares of common stock, that will be valued at $1.00 per share, respectively. As part of the Agreement, Mr. Robert DeAngelis will also resign and appoint new officers and directors as to be chosen by the Companies. The Company plans to bring Mr. DeAngelis back as a consultant and / or an advisor, but no agreements have been made to do so, at this time.

The 15,015,002 shares of Common Stock and 500,000 shares of Preferred Stock will be distributed as described below:

Common Stock

Shares to Issue	Shareholder
1,876,875	Efrat Afek
1,876,875	Ralph Milman
3,753,751	Ronan Koubi
3,003,000	The Q Trust
2,552,551	Ronald Minsky
1,951,950	The Apollo Family Trust

Series A Preferred Stock

Shares to Issue	Shareholder
62,500	Ralph Milman
62,500	Efrat Afek
125,000	Ronan Koubi
105,000	The Q Trust
80,000	Ronald Minsky
65,000	The Apollo Family Trust

The Agreement may be terminated, and the Acquisition contemplated herein may be abandoned at any time prior to the Effective Time, whether before or after stockholder approval thereof by either Acquiror or the Companies.

On April 16, 2020, the Company issued 400,000 shares of common stock to its President and Chief Executive Officer pursuant to the terms of his employment agreement. The shares were issued as a performance bonus for 2020 and were valued at the quoted market price on the date of issuance.

On April 23, 2020, the Company issued 2,000,000 shares of common stock to its President and Chief Executive Officer pursuant to the terms of his employment agreement. The shares were issued as a performance bonus for 2020 and were valued at the quoted market price on the date of issuance.

Effective June 22, 2020, Robert DeAngelis resigned from his position as President and Chief Executive Officer and as a member of the board of directors of REAC Group, Inc. Ronen Koubi will be appointed the new CEO. Ronen Koubi is the President and Director of Florida Beauty Flora, Inc.

Effective July 29, 2020, the Company entered into a securities purchase agreement with Auctus Fund, LLC, a Delaware limited liability company. The SPA provides for the purchase by Auctus of a convertible promissory note in the principal amount of $575,000; including 100% warrant coverage with full anti-dilution rights and buyback option. The Company authorized the disbursement of the proceeds of this Note to Florida Beauty Flora, Inc.. The Promissory Note matures on July 29, 2021 and bears interest at a rate of 12% per annum.

Effective October 12, 2020, one of the Company’s convertible promissory notes dated March 13, 2017, with the original principal amount of $230,000, was assigned to a new third party. All rights, title, and interest of the Note were assigned without recourse and without representations or warranties of any kind.

24

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion provides information which management believes is relevant to an assessment and understanding of our results of operations and financial condition. The discussion should be read along with our financial statements and notes thereto contained elsewhere in this Report. The following discussion and analysis contains forward-looking statements, which involve risks and uncertainties. Our actual results may differ significantly from the results, expectations and plans discussed in these forward-looking statements.

The following plan of operation provides information which management believes is relevant to an assessment and understanding of our results of operations and financial condition. The discussion should be read along with our financial statements and notes thereto. This section includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like believe, expect, estimate, anticipate, intend, project and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our predictions.

Plan of Operations

Our plan of operation is to operate a real estate search engine portal website. We want to position our company as a national real estate search engine/social community network that matches buyers, sellers, brokers, and professionals anywhere in the world.

What Makes us Different

Real Estate professionals use the internet to generate leads. The top sources of internet leads are company and agent websites. Each real estate professional on our website will be the EXCLUSIVE agent in the city that they service in and will have their own profile page that contains the agent’s information and bios with links to their listings. Each agent will also have their own exclusive city page that will feature advertising banners from various other local businesses that work in the real estate field such as local mortgage brokers, title companies, real estate attorneys, contractors, among others in the real estate profession.

Products and Services

Our new real estate search website, https://realestatecontacts.com/, will allow real estate professionals and consumers to interact through the internet as a business medium and features the real estate professional’s current listings and profiles in their geographic service areas enabling potential home buyers to view real estate listings and homes that are for sale and featured on the real estate professional’s website. This format is called a “lead-generation” program for real estate professionals that are on the https://realestatecontacts.com/portal website.

We aim to offer real estate agents, brokers, and offices the opportunity to become the exclusive real estate contact in the city that they serve on https://realestatecontacts.com/for a yearly fee.

We believe our services will empower consumers and drive more business for real estate professionals as well as small business owners. Participating real estate brokers, offices and agents receive coverage in the cities, areas and territories that they service.

The Company plans to generate its revenue from selling advertising to real estate professionals on our real estate portal.

Our business strategy is having the agent, broker, or office be exclusive in their city which will eliminate all of their competition for that city. For this reason we believe our concept will have a high level of interest from any real estate professional.

Currently, while there are other real estate directories and portals on the internet, no one features real estate agents on exclusive basis. We believe this approach will be attractive to real estate professionals in each locale.

25

We plan to grow revenues from the advertising sales from real estate professionals on our current website in the next 12 months by undertaking the following steps:

· Devote greater resources to marketing and selling our services such as developing and creating a more productive advertising sales division within our company by the hiring of advertising sales account executives.

· Focus to expand our network of advertisers and real estate professionals by increasing our online presence to include various marketing channels such as the major search engines, Google, Yahoo and Bing.

· Expand our company’s public relations by creating more brand awareness on the internet. An example would be to focus on other social media websites such as Facebook, Twitter, and LinkedIn.

· Develop other marketing programs to efficiently increase our brand awareness such as email campaigns, newsletters, linking our website to other real estate business websites, real estate portals and directories.

· We intend to continue, maintain and aggressively pursue to build our advertising campaign around all internet related marketing concepts, such as search engine optimization, banner advertising and social media networks to help manage and geographically target consumer traffic and lead volume.

· We plan to increase our online Search Engine Marketing to create more unique users Focus on driving more internet traffic and unique visitors to our websites by using these search engine marketing techniques.

The number of real estate professionals (advertisers) on our website is an important driver of revenue growth because each advertiser will pay a yearly fee to participate in the advertising of their services on our website.

Limited Operating History

We have generated a limited financial history and have not previously demonstrated that we will be able to expand our business through increased investment in marketing activities. We cannot guarantee that the expansion efforts described in this Registration Statement will be successful. The business is subject to risks inherent in growing an enterprise, including limited capital resources and possible rejection of our business model and/or sales methods.

Future financing may not be available to us on acceptable terms. If debt financing is not available or not available on satisfactory terms, we may be unable to continue expanding our operations. Equity financing will result in a dilution to existing shareholders.

For the three months ended March 31, 2019 compared to the three months ended March 31, 2018

The Company earned no revenues for the three month periods ended March 31, 2019 and 2018, respectively.

Operating expenses were $3,151,338 and $372,707 for the three month periods ended March 31, 2019 and 2018 and interest expense was $31,972 and $18,334, respectively. The Company recorded a loss of $3,197,403 for the three months ended March 31, 2019 as compared to a loss of $355,994 for the three months ended March 31, 2018. The change reflects stock compensation issued to the Company’s executive officer in the current period.

Capital Resources and Liquidity

The Company is currently financing its operations primarily through loans, equity sales and advances from shareholders. We believe we can currently satisfy our cash requirements for the next six months with our expected capital to be raised in private placement and sales of our common stock. Additionally, we will begin to use our common stock as payment for certain obligations and to secure work to be performed.

At March 31, 2019, the Company has cash in the amount of $261. The Company anticipates earning revenue, which will mitigate partial cash flow deficiencies, however at the present time we do not have revenues to cover our cash requirements. Management does not believe that is has adequate cash resources to meet the requirements to develop certain aspects of our business plan, however, should be sufficient to meet our current obligations, as the amount represents approximately nine months to one year of our run rate of operating expenses. In consideration of the potential shortfall in adequate resources, management has disclosed its going concern and believes that financial support from the majority shareholder to pay minimal and necessary incurred expense will allow the Company to benefit from advertising revenue streams, currently in-place, to produce the anticipated cash flow necessary to support operations.

As of March 31, 2019, we had negative working capital of $1,545,071 and we have net cash used of $11,696 in our operating activities.

We do believe that we will have enough cash to support our daily operations, at reduced levels of development, beyond the next 12 months while we are attempting to expand operations and produce revenues. Although we believe we have adequate funds to maintain our current operations for the near term, we do not believe that we have the required funding to expand our product offering (web video channel and other possible alternative service offerings). We estimate the Company needs an additional $200,000 to fully implement its business plans over the next twelve months. In addition, we anticipate we will need an additional minimum of $120,000 to cover operational and administrative expenses for the next twelve months. The majority shareholder has committed to cover any cash shortfalls of the Company, although there is no written agreement or guarantee. If we are unable to satisfy our cash requirements we may be unable to proceed with our plan of operations.

26

Future financing for our operations may not be available to us on acceptable terms. To raise equity will require the sale of stock and the debt financing will require institutional or private lenders. We do not have any institutional or private lending sources identified. If debt financing is not available or not available on satisfactory terms, we may be unable to continue expanding our operations. Equity financing will result in a dilution to existing shareholders.

The foregoing represents our best estimate of our cash needs based on current planning and business conditions. In the event we are not successful in reaching our initial revenue targets, additional funds may be required, and we may not be able to proceed with our business plan for the development and marketing of our core services. Should this occur, we will suspend or cease operations.

We anticipate that depending on market conditions and our plan of operations, we may incur significant continuing operating losses in the foreseeable future. Therefore, our auditors have raised substantial doubt about our ability to continue as a going concern.

Management Consideration of Alternative Business Strategies

In order to continue to protect and increase shareholder value management believes that it may, from time to time, consider alternative management strategies to create value for the company or additional revenues. Strategies to be reviewed may include acquisitions; roll-ups; strategic alliances; joint ventures on large projects; issuing common stock as compensation in lieu of cash; and/or mergers.

Management will only consider these options where it believes the result would be to increase shareholder value while continuing the viability of the company. At the current time, there have been no planned commitments to any independent considerations mentioned above.

Recent Accounting Pronouncements

The Financial Accounting Standards Board and other standard-setting bodies issued new or modifications to, or interpretations of, existing accounting standards during the year. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial position or operations in the near term. These recently issued pronouncements have been addressed in the notes to the financial statements included in this filing.

Critical Accounting Policies and Estimates

Use of Estimates

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Our significant estimates include valuation of stock based compensation, derivative liabilities, and deferred tax valuation allowances. We evaluate our estimates on an ongoing basis. Actual results may differ from these estimates under different assumptions or conditions.

Revenue Recognition

ASU 2014-09, Revenue - Revenue from Contracts with Customers

On January 1, 2018, we adopted the new accounting standard ASC 606 and the related amendments. In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, Revenue from Contracts with Customers, to replace the existing revenue recognition criteria for contracts with customers. In August 2015, the FASB issued ASU No. 2015-14, Deferral of the Effective Date, to defer the effective date of ASU No. 2014-09 to interim and annual periods beginning after December 15, 2017. Subsequently, the FASB issued ASU No. 2016-08, Principal versus Agent Considerations, ASU No. 2016-10, Identifying Performance Obligations and Licensing, ASU No. 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting, ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements, to clarify and amend the guidance in ASU No. 2014-09.

In all cases, revenue is recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed, and collectability is reasonably assured.

Consideration for future advertising services are made by customers in advance of those services being provided. Advertising revenue is recognized ratably over the period that the services are subscribed, generally a one year period. The unearned portion of the advertising revenue is deferred until future periods in which the subscription is earned.

The Company has not issued guarantees or other warrantees on the advertising subscription success or results. The Company has not experienced any refund requests or committed to any adjustments for terminated subscriptions. The Company does not believe that there is any required liability.

27

Share-based Compensation

In December 2004, the FASB issued FASB ASC No. 718, Compensation – Stock Compensation (“ASC 718”). Under ASC 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant. The Company applies this statement prospectively.

In July 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. This update addresses several aspects of the accounting for nonemployee share-based payment transactions and expands the scope of ASC 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The main provisions of the update change the way nonemployee awards are measured in the financial statements. Under the simplified standards, nonemployee options will be valued once at the date of grant, as compared to at each reporting period end under ASC 505-50. At adoption, all awards without established measurement dates will be revalued one final time, and a cumulative effect adjustment to retained earnings will be recorded as the difference between the pre-adoption value and new value. Companies will be permitted to make elections to establish the expected term and either recognize forfeitures as they occur or apply a forfeiture rate. Compensation expense recognition using a graded vesting schedule will no longer be permitted. This pending content is the result of the FASB’s Simplification Initiative, to maintain or improve the usefulness of the information provided to the users of financial statements while reducing cost and complexity in financial reporting. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. Early adoption is permitted, but no earlier than an entity’s adoption date of Topic 606. Because the Company does not currently have any outstanding awards to non-employees for which a measurement date has not been established the adoption of ASU 2018-07 does not have a material impact to the Company’s financial statements and related disclosures upon adoption. The adoption of this standard will change the way that the Company accounts for non-employee compensation in the future.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a Smaller Reporting Company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

A material weakness is a control deficiency (within the meaning of the Public Company Accounting Oversight Board (PCAOB) auditing standard) or combination of control deficiencies that result in more than remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected.

(a) Evaluation of disclosure controls and procedures. Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) (the Company’s principal financial and accounting officer), of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures are not effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

The Company is a small company with limited resources and there is insufficient staff for segregation of duties of accounting functions and for levels of review of our report filings. Due to these constraints, management considers that a material weakness in financial reporting currently exists. Subsequent to the filing of the original Form 10Q ending March 31, 2019, the Company was caused to file this amended report due to deficiencies in the segregation of duties and its internal review of accounting transactions.

(b) Changes in internal control over financial reporting. There have been changes in our internal control over financial reporting that occurred subsequent to the filing of the original Form 10Q ending March 31, 2019. These changes are expected to have a material effect, or are reasonably likely to materially affect, our internal control over financial reporting.

On April 13, 2020, we entered into a second Amended Agreement and Plan of Share Exchange Agreement with Florida Beauty Express, Inc., Florida Beauty Flora, Inc., Floral Logistics of Miami, Inc., Floral Logistics of California, Inc., Tempest Transportation Inc. (the “Companies”) and Companies shareholders. As a result, the Company has expanded its management and board of directors and believes certain controls such as segregation of duties and levels of review related to our report filings will add reasonable assurances that these deficiency risks will be mitigated in the future.

28

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

We are a Smaller Reporting Company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During the three months ended March 31, 2019, the Company issued 4,900 shares of common stock for conversion of convertible note principal of $1,500 and accrued interest of $1,420.

On March 31, 2019, the Company’s Board of Directors authorized the issuance of 15,000,000 shares to the Company’s Chief Executive Officer as a performance bonus pursuant to his employment agreement. The shares were valued at $0.20, the quoted market price on the date of issuance, or $3,000,000.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosure.

None.

Item 5. Other Information.

None.

29

Item 6. Exhibits.

Exhibit Number	Description
31.1	Certification by the Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Filed herewith
32.1	Certification by the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C Section 1350 pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Filed herewith
101*	Financial statements from the quarterly report on Form 10-Q of REAC GROUP, , Inc. for the quarter ended March 31, 2019, formatted in XBRL: (i) the Balance Sheet, (ii) the Statement of Income, (iii) the Statement of Cash Flows and (iv) the Notes to the Financial Statements. Filed herewith

*Pursuant to Rule 406T of Regulation S-T, the XBRL files contained in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

30

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	REAC GROUP, INC.
Dated: September 29, 2021	By:	/s/RONEN KOUBI
		Ronen Koubi
		President,
		Principal Executive Officer, Principal Financial Officer Principal Accounting Officer and Director

31

EX-31.1

EXHIBIT 31.1

Certification of Principal Executive Officer and Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

and Securities and Exchange Commission Release 34-46427

I, Ronen Koubi, certify that:

1.	I have reviewed this report on Form 10-Q/A of REAC GROUP, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

a)	designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	disclosed in this report any change in registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of the annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: September 29, 2021	By:	/s/ RONEN KOUBI
		Ronen Koubi
		President
		Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and Director

EX-32.2

EXHIBIT 32.1

Certification of Principal Executive Officer and Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of REAC GROUP, Inc. (the “Company”) on Form 10-Q/A for the period ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ronen Koubi, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: September 29, 2021	By:	/s/ RONEN KOUBI
		Ronen Koubi
		President
		Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and Director

XML

Cover - shares	3 Months Ended
	Mar. 31, 2019	Jun. 01, 2021
Cover [Abstract]
Entity Registrant Name	REAC GROUP, INC.
Entity Central Index Key	0001520528
Document Type	10-Q/A
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2019
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2019
Entity Common Stock Shares Outstanding		28,933,048
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-54845
Entity Incorporation State Country Code	FL
Entity Tax Identification Number	59-3800845
Entity Address Address Line 1	3400 NW 74th Street
Entity Address City Or Town	Miami
Entity Address State Or Province	FL
Entity Address Postal Zip Code	33122
City Area Code	305
Local Phone Number	503-1200
Entity Interactive Data Current	Yes

XML

Balance Sheets - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current assets
Cash	$ 261	$ 1,162
Total current assets	261	1,162
Total assets	261	1,162
Current liabilities
Accounts payable	17,500	3,000
Accrued interest	78,677	54,119
Accrued salaries, payroll taxes and related expenses	931,948	807,108
Convertible notes payable, net of discounts of $-0- and $4,915, respectively	506,412	488,823
Due to principal shareholder, related party	10,795	0
Total current liabilities	1,545,332	1,353,050
Total liabilities	1,545,332	1,353,050
Commitments and Contingencies (Note 12)	0	0
Stockholders' Deficit
Common Stock, $0.00001 par value, 200,000,000 shares authorized; 15,057,517 and 50,441 shares issued and outstanding, respectively	150	0
Additional paid-in capital	25,038,765	22,034,695
Accumulated deficit	(26,584,036)	(23,386,633)
Total stockholders' deficit	(1,545,071)	(1,351,888)
Total Liabilities and Stockholders' Deficit	261	1,162
Preferred Stock A [Member]
Stockholders' Deficit
Preferred stock value	50	50
Preferred Stock B [Member]
Stockholders' Deficit
Preferred stock value	$ 0	$ 0

XML

Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current liabilities
Convertible notes payable, net of discounts	$ 0	$ 4,915
Stockholders' Deficit
Common Stock, Par Value	$ 0.00001	$ 0.00001
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Shares Issued	15,057,517	50,441
Common Stock, Shares Outstanding	15,057,517	50,441
Preferred Stock A [Member]
Stockholders' Deficit
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	500,000	500,000
Preferred Stock, Shares Issued	500,000	500,000
Preferred Stock, Shares Outstanding	500,000	500,000
Preferred Stock B [Member]
Stockholders' Deficit
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	500,000	500,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0

XML

Statements of Operations (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Statements of Operations (unaudited)
Revenues	$ 0	$ 0
Operating expenses:
Compensation and related costs	3,124,840	352,949
Professional	26,030	18,554
General and administrative	468	1,204
Total operating expenses	3,151,338	372,707
Loss from operations	(3,151,338)	(372,707)
Other income (expense):
Interest expense	(31,971)	(18,334)
Debt financing penalties	(14,094)	0
Gain on write off of warrant liability	0	35,047
Total other income (expense)	(46,065)	16,713
Loss before provision for income taxes	(3,197,403)	(355,994)
Provision for income taxes	0	0
Net (Loss)	$ (3,197,403)	$ (355,994)
(Loss) per share, basic and dilutive	$ (0.41)	$ (18.27)
Weighted average shares outstanding, basic and dilutive	7,784,185	19,486

XML

Statements of Changes in Stockholders' Deficit (unaudied) - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Dec. 31, 2017		50,935	9,364
Balance, amount at Dec. 31, 2017	$ (1,200,879)	$ 5	$ 0	$ 21,483,185	$ (22,684,069)
In kind contribution of rent	300	0	$ 0	300	0
Common shares issued as compensation and for services, shares			10,000
Common shares issued as compensation and for services, amount	330,000	$ 0	$ 0	330,000	0
Preferred shares issued as compensation and for services, shares		449,065
Preferred shares issued as compensation and for services, amount	112,266	$ 45		112,221
Shares issued in satisfaction of loan debt and interest, shares			5,931
Shares issued in satisfaction of loan debt and interest, amount	45,430	0	$ 0	45,430	0
Net loss for the three months	(355,994)	$ 0	$ 0	0	(355,994)
Balance, shares at Mar. 31, 2018		500,000	25,295
Balance, amount at Mar. 31, 2018	(1,068,877)	$ 50	$ 0	21,971,136	(23,040,063)
Balance, shares at Dec. 31, 2018		500,000	50,441
Balance, amount at Dec. 31, 2018	(1,351,888)	$ 50	$ 0	22,034,695	(23,386,633)
In kind contribution of rent	300	0	$ 0	300	0
Common shares issued as compensation and for services, shares			15,000,000
Common shares issued as compensation and for services, amount	3,000,000	0	$ 150	2,999,850	0
Shares issued in satisfaction of loan debt and interest, shares			4,900
Shares issued in satisfaction of loan debt and interest, amount	3,920	0	$ 0	3,920	0
Net loss for the three months	(3,197,403)	$ 0	$ 0	0	(3,197,403)
Fractional shares issued in stock split, shares			2,176
Fractional shares issued in stock split, amount	0		$ 0		0
Balance, shares at Mar. 31, 2019		500,000	15,057,517
Balance, amount at Mar. 31, 2019	$ (1,545,071)	$ 50	$ 150	$ 25,038,765	$ (26,584,036)

XML

Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flows from Operating Activities:
Net loss	$ (3,197,403)	$ (355,994)
Adjustment to reconcile net loss to net cash used in operations:
Stock based compensation	3,000,000	330,000
In kind contribution of rent	300	300
Amortization of debt discounts and financing costs	5,915	19,564
Debt financing penalties	14,094	0
Gain on write off of warrant liability	0	(35,047)
Changes in assets and liabilities:
Accounts payable	14,500	0
Accrued interest	26,058	(1,230)
Accrued salaries, payroll taxes and related expenses	124,840	3,683
Net Cash Used in Operating Activities	(11,696)	(38,724)
Cash Flows from Financing Activities:
Proceeds from notes payable, principal shareholder	11,355	0
Repayments of notes payable, principal shareholder	(560)	(47)
Net Cash (Used)/Provided by Financing Activities	10,795	(47)
Net (decrease)/increase in cash	(901)	(38,771)
Cash at beginning of period	1,162	51,396
Cash at end of period	261	12,625
Supplemental cash flow information:
Interest paid	0	0
Taxes paid	0	0
Non-cash disclosures:
Common stock issued for principal and interest on convertible notes	3,920	45,430
Preferred stock issued against accrued officer compensation	$ 0	$ 112,266

XML

Background Information

3 Months Ended

Mar. 31, 2019

Background Information

1. Background Information

1. Background Information

REAC Group, Inc. (“The Company”) was formed on March 10, 2005 under the name of Real Estate Contacts, Inc. as a Florida Corporation and is based in Pittsburgh, Pennsylvania. The Company changed its name to REAC Group, Inc. effective February 16, 2017. The Company engages in the ownership and operation of a real estate advertising portal website. The Company plans to provide a comprehensive online real estate search portal that consists of an advertising and marketing platform for real estate professionals. The Company’s national real estate search website is www.realestatecontacts.com.

The Company’s website offers cities to real estate professionals so they can grow their businesses online and have the opportunity to show their listings and reach consumers interested in buying or selling property in their respective exclusive geographic areas.

RealEstateContacts.com is expected to serve as an internet portal that will feature a real estate search website that directs consumers to receive more detailed information about agents, offices, and current listings, homes for sale, commercial properties, mortgages, and foreclosures. We intend to provide a service that enables real estate professionals to capture, cultivate, and convert leads which cater to prospective home buyers and sellers. The Company is seeking to bring additional value to its shareholders through acquisition, joint venture, or partnerships with other real estate related businesses. The Company intends to add to their business model by acquiring real estate such as multi-family and residential income producing properties. The Company is interested with the possibilities to Acquire, Joint Venture or Partner with other real estate related businesses along with other new business opportunities with established business entities and revenues. We will continue to introduce our operational progress and other corporate actions that include our plan of growth.

XML

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2019

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

The Balance Sheet as of March 31, 2019, the Statements of Income for the three months ended March 31, 2019 and 2018, the Statements of Stockholders’ Deficit for the three months ended March 31, 2019 and 2018, and the Statements of Cash Flows for the three months ended March 31, 2019 and 2018 are unaudited. These unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP). In our opinion, the unaudited interim financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of March 31, 2019, our results of operations for the three months ended March 31, 2019 and 2018, and our cash flows for the three months ended March 31, 2019 and 2018. The results of operations for the three months ended March 31, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019.

These unaudited interim financial statements should be read in conjunction with the financial statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC.

All share and per share information contained in this report gives retroactive effect to a 1 for 10,000 reverse stock split of outstanding common stock, effective March 1, 2019.

Use of Estimates

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Our most significant estimates are for stock based compensation; assumptions used in calculating derivative liabilities, and deferred tax valuation allowances. We evaluate our estimates on an ongoing basis. Actual results may differ from these estimates under different assumptions or conditions.

Financial Instruments

The Company’s balance sheets include the following financial instruments: cash, accrued expenses, notes payable and payables to a stockholder. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. The carrying values of the notes payable and amounts due to stockholder approximates fair value based on borrowing rates currently available to the Company for instruments with similar terms and remaining maturities.

FASB Accounting Standards Codification (ASC) topic, “Fair Value Measurements and Disclosures”, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

· Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities

· Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

· Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2019.

Derivative Liabilities

The Company assessed the classification of its derivative financial instruments as of March 31, 2019 and 2018, which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815.

During the three months ended March 31, 2019 and 2018, respectively, the Company had notes payable outstanding in which the conversion rate was variable and undeterminable. The Company uses judgment in determining the fair value of derivative liabilities at the date of issuance and at every balance sheet thereafter and in determining which valuation method is most appropriate for the instrument, the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate, if any. For the three months ended March 31, 2019, the Company determined that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there was no derivative liability associated with these convertible notes for the period.

Beneficial Conversion Features

ASC 470-20 applies to convertible securities with beneficial conversion features that must be settled in stock and to those that give the issuer a choice in settling the obligation in either stock or cash. ASC 470-20 requires that the beneficial conversion feature should be valued at the commitment date as the difference between the conversion price and the fair market value of the common stock into which the security is convertible, multiplied by the number of shares into which the security is convertible. This amount is recorded as a debt discount and amortized over the life of the debt. ASC 470-20 further limits this amount to the proceeds allocated to the convertible instrument.

Cash Flow Reporting

The Company follows ASC 230, Statement of Cash Flows, for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.

Cash and Cash Equivalents

Cash is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed on demand and, therefore, bear minimal risk. The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company had no cash equivalents at either March 31, 2019 or 2018.

Long-Lived Assets

In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-lived asset exceeds its fair value.

Stock Based Compensation

Under ASC 718, Compensation – Stock Compensation, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

Equity instruments (“instruments”) issued to other than employees are recorded on the basis of the fair value of the instruments, as required by FASB ASC 718. FASB ASC No. 505, Equity Based Payments to Non-Employees (“ASC 505”) defines the measurement date and recognition period for such instruments. In general, the measurement date is (a) when a performance commitment, as defined, is reached or (b) when the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the ASC 505.

Income Taxes

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

Earnings Per Share

Basic income per common share is computed based upon the weighted average common shares outstanding as defined by FASB ASC No. 260, Earnings Per Share.

Diluted income per share includes the dilutive effects of stock options, convertible debt, warrants, and stock equivalents. To the extent stock options, stock equivalents and warrants are anti-dilutive; they are excluded from the calculation of diluted income per share. As of March 31, 2019, there were approximately 3,597,620 share equivalents for potential conversion demand of our outstanding convertible notes and warrants.

XML

Restatement of financial statements

3 Months Ended

Mar. 31, 2019

Restatement of financial statements

3. Restatement of financial statements

3. Restatement of financial statements

The following reflects changes to the accounts affected as a result of the restatement:
Changes to the Balance Sheet	As originally filed			As restated			Change Increase/ (decrease)
Accrued Interest	$	50,165		$	78,677		$	28,513
Convertible Notes Payable	$	273,709		$	506,412		$	232,703
Changes to Other Income and Expense
Interest Expense	$	31,541		$	31,972		$	431
Debt financing penalties	$	---		$	14,094		$	14,094
Gain on Settlement of Debt	$	246,691		$	-		$	(246,691	)
The following reflects changes to the balance sheet as a result of the restatement:
Liabilities and Stockholders’ Deficit
Current liabilities	As originally filed			As restated			Change Increase/ (decrease)
Accounts payable	$	17,500		$	17,500		$	-
Accrued interest		50,165			78,677			28,513
Accrued salaries and taxes		931,948			931,948			-
Due to principle shareholder, related party		10,795			10,795			-
Convertible notes payable		273,709			506,412			232,703
Total current liabilities		1,284,117			1,545,332			261,215
Stockholders’ Deficit
Preferred Stock, Series A $.0001 par value, 500,000 shares authorized; none issued and outstanding		50			50			-
Preferred Stock, Series B $.001 par value, 500,000 shares authorized; none issued and outstanding		-			-			-
Common Stock, $0.00001 par value, 199,000,000 shares authorized15,057,517 and 9,364 issued and outstanding, respectively		150			150			-
Common stock payable		-			-			-
Additional paid-in capital		25,038,765			25,038,765			-
Accumulated deficit		(26,569,799	)		(26,584,036	)		(261,215	)
Total stockholders’ deficit	$	(1,530,834	)	$	(1,545,071	)	$	(261,215	)
The following reflects changes to net income and loss per share as a result of the restatement:
	As originally filed			As restated			Change Increase/ (decrease)
Net income/(loss)	$	(2,936,188	)	$	(3,197,403	)	$	(261,215	)
Loss per share, basic and dilutive	$	(0.70	)	$	(0.41	)	$	0.29
Weighted average shares outstanding, basic and dilutive		4,221,826			7,784,185			3,597,620

XML

Going Concern

3 Months Ended

Mar. 31, 2019

Going Concern

4. Going Concern

4. Going Concern

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern.

The Company incurred net losses of $3,197,403 for the three months ended March 31, 2019 and had net cash used in operating activities of $11,696 for the same period. Additionally, the Company has an accumulated deficit of $26,584,036 and a working capital deficit of $1,545,071 at March 31, 2019. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of at least twelve months after the date of issuance on these financial statements. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to achieve a level of profitability and/or to obtain adequate financing through the issuance of debt or equity in order to finance its operations.

While the Company is attempting to commence operations and produce revenues, the Company’s cash position may not be significant enough to support the Company’s operations. While the Company believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. The key factors that are not within the Company’s control and that may have a direct bearing on operating results include, but are not limited to, acceptance of the Company’s business plan, the ability to raise capital in the future, the ability to expand its customer base, and the ability to hire key employees to build and maintain websites and to provide services and support to its customers and users. There may be other risks and circumstances that management may be unable to predict.

The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

XML

Recently Issued Accounting Pronouncements

3 Months Ended

Mar. 31, 2019

Recently Issued Accounting Pronouncements

5. Recently Issued Accounting Pronouncements

5. Recently Issued Accounting Pronouncements

We have reviewed all FASB issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.

In July 2018, FASB issued Accounting Standards Update 2018-11; Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480): Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Non-public Entities and Certain Mandatorily Redeemable Non-controlling Interests with a Scope Exception. The guidance is intended to reduce the complexity associated with issuers’ accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, a down round feature (as defined) would no longer cause a freestanding equity-linked financial instrument (or an embedded conversion option) to be accounted for as a derivative liability at fair value with changes in fair value recognized in current earnings. The amendments in this ASU are effective for interim and annual periods beginning after December 15, 2018. Early adoption is permitted. We adopted Topic 718 effective January 1, 2019 and management believes that the standard will not have a significant effect on our results of operations or cash flows.

In May 2018, FASB issued Accounting Standards Update 2018-09; Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting. The amendments in this ASU amends the scope of modification accounting for share-based payment arrangements, provides guidance on the types of changes to the terms or conditions of share-based payment awards an entity is required to apply modification accounting under ASC 718. The amendments in this ASU are effective for interim and annual periods beginning after December 15, 2018. Early adoption is permitted. We adopted Topic 718 effective January 1, 2019 and management believes that the standard will not have a significant effect on our results of operations or cash flows.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes ASC 840, Leases. This ASU is based on the principle that entities should recognize assets and liabilities arising from leases. The ASU does not significantly change the lessees’ recognition, measurement and presentation of expenses and cash flows from the previous accounting standard. Leases are classified as finance or operating. The ASU’s primary change is the requirement for entities to recognize a lease liability for payments and a right of use asset representing the right to use the leased asset during the term on operating lease arrangements. Lessees are permitted to make an accounting policy election to not recognize the asset and liability for leases with a term of twelve months or less. Lessors’ accounting under the ASC is largely unchanged from the previous accounting standard. In addition, the ASU expands the disclosure requirements of lease arrangements. Lessees and lessors will use a modified retrospective transition approach, which includes a number of practical expedients. The effective date will be the first quarter of fiscal year 2020 with early adoption permitted. We adopted Topic 842 effective January 1, 2019 and management believes that the standard will not have a significant effect on our results of operations or cash flows.

XML

Related Party Transactions

3 Months Ended

Mar. 31, 2019

Related Party Transactions

6. Related Party Transactions

6. Related Party Transactions

The majority shareholder has advanced funds since inception, for the purpose of financing working capital and product development. As of March 31, 2019 and 2018, the Company owed $10,795 and $0, respectively. There are no repayment terms to these advances and deferrals and the Company has imputed interest at a nominal rate of 3%.

The Company has minimal needs for facilities and operates from office space provided by the majority shareholder. There are no lease terms. For the three months ended March 31, 2019 and 2018, rent has been calculated based on the limited needs at a fair market value of the space provided. Rent expense was $300 and $300 for the three months ended March 31, 2019 and 2018, respectively. The rental value has been recognized as an operating expense and treated as a contribution to capital.

The amounts and terms of the above transactions may not necessarily be indicative of the amounts and terms that would have been incurred had comparable transactions been entered into with independent third parties.

On March 31, 2019, the Company’s Board of Directors authorized the issuance of 15,000,000 shares to the Company’s Chief Executive Officer as a performance bonus pursuant to his employment agreement. The shares were valued at $0.20, the quoted market price on the date of issuance, or $3,000,000.

On March 1, 2018, the Company issued 45 shares of the Company’s Series A Preferred Shares to its sole director and chief executive officer in satisfaction of accrued compensation owed to him by the Company. (See Note 11).

On January 23, 2018, the Company issued 10,000 shares of its common stock to sole officer and director, Robert DeAngelis, as his 2017 annual bonus per his employment agreement. The annual bonus, if any, is determined and paid in accordance with policies set from time to time by the Board or Directors, in its sole discretion. The Board’s policy has been to base the stock price for such issuances upon the average of the closing price of the preceding 10 trading days as reported on OTC Markets website, which was $33.00; rendering the value of the preferred issued as $330,000. Since the Company’s closing stock price on the date of grant was also $33.00, the Company did not recognize any associated discounts or benefits associated with the shares issued.

On March 4, 2019, the Company renewed its three-year employment agreement with Robert DeAngelis to serve as the President and Chief Executive Officer of the Company. The employment agreement automatically renews for an additional twelve months upon expiration of each term. The agreement can be cancelled upon written notice by either employee or employer (if certain employee acts of misconduct are committed). The total minimum aggregate annual amount due under the employment agreement is $120,000 plus bonuses. For the three months ended March 31, 2019 and 2018, the Company recorded compensation expense in the amount of $30,000 and $30,000, respectively.

XML

Accrued Liabilities

3 Months Ended

Mar. 31, 2019

Accrued Liabilities

7. Accrued Liabilities

7. Accrued Liabilities

Accounts Payable and Accrued expenses:
	March 31, 2019		December 31, 2018
Accounts payable	$	17,500	$	3,000
Accrued interest		78,677		54,119
Accrued salaries, payroll taxes, penalties and interest (a)		931,948		807,108
Due to principle shareholder, related party		10,795		---

(a) The Company has accrued additional compensation to its Chief Executive Officer totaling $30,000 and $30,000 during the three months ended March 31, 2019 and 2018, respectively. However, the Company has not paid the related payroll taxes, consisting primarily of Social Security and Medicare taxes. As a result, the Company has established an accrued liability for the unpaid salaries, along with related taxes and estimated interest and penalties of $931,948 and $807,108 at March 31, 2019 and December 31, 2018, respectively.

XML

Convertible Notes Payable

3 Months Ended

Mar. 31, 2019

Convertible Notes Payable

8. Convertible Notes Payable

8. Convertible Notes Payable

During the three months ended March 31, 2019 and 2018, respectively, the Company had convertible notes payable outstanding in which the conversion rate was variable and undeterminable. The Company determined that there wasn’t an active market for the Company’s common stock and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with these convertible notes as of March 31, 2019 and March 31, 2018. The Company uses judgment in determining the fair value of derivative liabilities at the date of issuance and at every balance sheet thereafter and in determining which valuation method is most appropriate for the instrument, the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate, if any.

As of March 31, 2019, all of the Company’s convertible promissory notes remain outstanding beyond their respective maturity dates; triggering an event of technical default under the respective agreements. Consequently, the Company is accruing interest on these notes at their respective default rates. As a result of being in default on these notes, the Holders could, at their sole discretion, call these Notes in their entirety, including all associated penalties provided for under the respective agreements. In this event, the Company may not have sufficient authorized shares to absolve itself of the defaulted Notes through the issuance of common shares of the Company. The Company is working with the current note holders and its transfer agent in order that it may resolve these outstanding issues as soon as practicable. On November 2, 2018, the Company received a formal letter from one of its Note Holders demanding payment of all amounts due under the Note plus applicable collection costs, including attorney’s fees at the Mandatory Default Amount. The varied terms and definitions of these default provisions are disclosed below in each of the respective Note disclosures.

As of March 31, 2019, the Company owed an aggregate of $585,089 in principal and accrued interest; of which, $506,412 (before a discount of $-0-) represents convertible notes payable and $78,677 represents accrued interest. At December 31, 2018, the Company owed an aggregate of $542,942 (before a discount of $4,915) in principal and accrued interest; of which, $493,738 represents convertible notes payable and $54,119 represents accrued interest.

	March 31, 2019		December31, 2018
Convertible promissory notes, various lending institutions, maturing at variable dates ranging from 180 days to one year from origination date, 8-10% interest and in default interest of 12-24%, convertible at discount to trading price (25-50%) based on various measurements of prior trading, at face value of remaining original note principal balance plus default penalties, net of unamortized debt discounts, attributable to derivative liabilities, and deferred financing costs in the amount of $-0- and $6,974, respectively.	$	506,412	$	493,738
Principal		506,412		493,738
Debt discount		---		(4,915	)
Total Principal	$	506,412	$	488,823

Summary of Convertible Note Transactions:
	March 31, 2019			December31, 2018
Convertible notes, January 1	$	493,738		$	364,721
Additional notes, face value		-			65,000
Default Penalties		14,094			172,886
Settlement of debt		-			(20,000	)
Conversions of debt		(1,420	)		(88,869	)
Unamortized debt discounts		-			(4,915	)
Convertible notes, balance	$	506,412		$	488,823

Note 6. On October 6, 2017, the Company entered into a Convertible Promissory Note with an accredited investor pursuant to which the Company received $150,000 in financing and an initial tranche of $20,000. Each tranche paid under the Note matures in 12 months and is convertible into shares of the Company’s common stock after a period of six months at a conversion price equal to 50% of the lowest trading price per share during the previous ten (10) trading days. The Company evaluated the terms of the convertible note in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock and determined that the underlying is indexed to the Company’s common stock. The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. During the year ended December 31, 2018, the Company determined that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note. On May 9, 2018, the note holder agreed to forgive the balance of the principal and accrued interest. As a result, during the year ended December 31, 2018, the Company has recognized a gain on the extinguishment of debt in the amount of $20,589 and canceled the reserve of 50,000 shares of common stock.

Note 5. On October 2, 2017, the Company received $53,000 in financing through the execution of a Convertible Promissory Note associated with a Securities Purchase Agreement. The Note bears interest at a rate of 12% and matures 280 days from the purchase date. The Note is convertible into shares of the Company’s common stock after a period of 180 days at a conversion price equal to 61% multiplied by the average of the lowest two trading prices during the previous fifteen (15) days. After 180 days following the Issue Date, the Company will have no right of prepayment. The Company evaluated the terms of the convertible note in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock and determined that the underlying is indexed to the Company’s common stock. The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. During the year ended December 31, 2018, the Company determined that there was no active market for the Company’s common stock. and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note. In addition, the Company issued an aggregate of 15,813 common shares in satisfaction of $53,000 in principal and $3,727 in accrued interest. As of December 31, 2018, the note was considered paid in full and the Company canceled the reserve of 41,945 shares of common stock.

Note 4. On July 8, 2017, the Company’s Board of Directors approved the assignment of a convertible note payable to a different third-party. The total amount assigned was $27,846 which includes principal of $20,775 and accrued interest of $7,087. The terms of the original February 20, 2015 Convertible Promissory Note remain in effect and the note continues to accrue interest at a rate of 8% per annum until the note is paid in full. In connection with the assignment, the Company issued 335 common shares for a value of $3,350, which was applied against the balance of accrued interest on the note. During the year ended December 31, 2018, the Company issued an aggregate of 1,125 common shares in satisfaction of $10,696 in principal and $554 in accrued interest for a total value of $11,250 and canceled the reserve of 49 shares of common stock. As of December 31, 2018, the note was considered paid in full.

Note 3. On July 5, 2017, the Company entered into a Securities Purchase Agreement and related documents with an institutional accredited investor. On the Closing Date, the Company issued a Convertible Promissory Note in the principal amount of $175,000 in exchange for payment by Investor of $157,500. The principal sum of the Note reflects the amount invested, plus a $17,500 “Original Issue Discount” and accrues interest at 5% per annum. The Holder has the right at any time to convert all or any part of unpaid principal and interest into common shares of the Company equal to 50% multiplied by the Market Price; that being the lowest (1) trading price for the common stock during the twenty-five trading days prior to the conversion date, subject to anti-dilution and market adjustments set forth in the Agreement.

In connection with the Financing, and in addition to the Securities Purchase Agreement and the Secured Convertible Promissory Note, the Company issued a Warrant which grants the investor the right to purchase at any time on or after each tranche, and for a period of five years thereafter, a number of fully paid and non-assessable shares of the Company’s common stock equal to the amount of each tranche received under the Note divided by $0.05. (See Note 9) On April 30, 2018, the Company’s Board of Directors approved the assignment of the Note to a different third-party. The total amount assigned was $30,306 which includes principal of $28,959 and accrued interest of $1,347. Subsequent to the assignment, the Company received additional tranches from the Assignee in the aggregate amount of $65,000 with no associated discounts. The Warrant associated with the Securities Purchase Agreement was not included in the Assignment of the Original Note.

The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. For the three months ended December 31, 2018, the Company concluded that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note.

The Note became due and payable on July 5, 2018 and the Company had defaulted on its obligations under the Note. Interest on the Note was then accrued at the default rate of 24% per annum and the Company classified the Note as a current liability. The Company is required to have authorized and reserved three and ten (10) times the number of shares that is actually issuable upon full exercise of the Note. The Note Holder could, at the Holder’s sole discretion, call the Note and impose the related default penalties. In this event, the Company would be obligated to pay 150% multiplied by the then outstanding entire balance and the Company would then also be in technical default of its Reserve requirement as it would have insufficient common shares authorized to cover the aggregate reserve requirement of all notes in default. As of March 31, 2019, the equivalent number of shares the Company would be required to issue to satisfy the Note is 316,880 and the Company is in technical default of the Reserve share requirement which is allocable between the Note and the detached Warrant (See Note 9).

During the three months ended March 31, 2019, no shares were issued against the note. As a result of the Company’s stock split effective March 1, 2019, the Company incurred a default penalty in the amount of $14, 094 and this was applied to the principal balance of the Note. During the year ended December 31, 2018, the Company issued an aggregate of 467 common shares in satisfaction of $6,041 in principal and fees under the Note of $500.

Note 2. On May 5, 2017, the Company entered into a Securities Purchase Agreement (“SPA”) with an institutional accredited investor pursuant to which the Company received $165,000 in financing through the execution of a Convertible Promissory Note. In addition, the Company issued 115 shares of common stock for a value of $63,415 as consideration for entering into the financing agreement. The Note matures in 10 months and is convertible into shares of the Company’s common stock at a conversion price equal to 50% of the lowest trading price per share during the previous twenty-five (25) trading days, subject to anti-dilution and market adjustments set forth in the Agreement.

The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. For the three months ended March 31, 2019 and 2018, the Company concluded that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note. The Company recognized a debt discount on the note as a reduction (contra-liability) to the Convertible Note Payable and is being amortized over the life of the note.

During the year ended December 31, 2018, the Company was required to increase the principal balance of the note by $5,000 pursuant to Section 1.3 of the Agreement which states that if the Borrower does not maintain or replenish the Reserved Amount within three (3) business days of the request of the Holder, the principal amount will increase by $5,000 for each such occurrence. In addition, under Section 1.4(g) of the Note, the Company was required to increase the principal amount of the Note by $15,000 due to the conversion price being less than $0.01. The penalties are tacked back to the Issue Date of the Note.

The Note became due and payable on February 5, 2018 and the Company remains in default of its obligations under the Note. Interest on the Note is being accrued at the default rate of 12% per annum and the Company classified the Note as a current liability. The Company is required to have authorized and reserved three and one half (3.5) times the number of shares that is actually issuable upon full exercise of the Note. On February 5, 2018, the Company was obligated to pay a Default Sum calculated as 150% multiplied by the then outstanding entire balance and recorded a penalty in the amount of $92,886 for failing to pay at maturity. As of March 31, 2019, the equivalent number of common shares the Company would be required to issue to satisfy the Note is 1,618,558.

During the three months ended March 31, 2019, the Company issued 4,900 common shares for a value of $3,920, satisfying $1,420 in principal, $1,500 in accrued interest, and $1,000 in finance costs. As of March 31, 2019, the Company owed $160,823 in principle, $112,886 in default penalties and accrued interest of $50,003. During the year ended December 31, 2018, the Company issued 3,300 common shares for a value of $6,480, satisfying $5,480 in principal and $1,000 in finance costs. As of December 31, 2018, the Company owed $275,129 in principle and accrued interest of $35,292.

Note 1. On March 13, 2017, the Company entered into an Agreement with an institutional Lender. On that date, the Company issued to the Lender a Secured Convertible Promissory Note in the principal amount of $230,000; of which, the Company has received $150,000 as of December 31, 2018. The principal sum of the Note reflects the amount borrowed, plus a $20,000 “Original Issue Discount” and a $10,000 reimbursement of Lender’s legal fees. On July 6, 2018, the Company’s Board of Directors approved the assignment of this Convertible Promissory Note to a different third-party. The terms of the original March 13, 2017 Convertible Promissory Note remain in effect and the note continues to accrue interest at a rate of 10% per annum until the note is paid in full.

In connection with the Financing, and in addition to the Securities Purchase Agreement and the Secured Convertible Promissory Note, the Company issued a Warrant which grants the right to purchase at any time on or after March 13, 2017 and for a period of three years, a number of fully paid and non-assessable shares of the Company’s common stock equal to $57,500 divided by the Market Price as of the issue date. (See Note 9) Effective on July 20, 2018, the Warrant to Purchase Shares previously issued under the March 13, 2017 Convertible Promissory Note was terminated by the Warrant holder to facilitate the Company’s fundraising efforts.

The Secured Convertible Promissory Note matures in 10 months and is convertible into shares of the Company’s common stock at a conversion price equal to $0.25 per share. In the event the minimum market capitalization falls below $6,000,000, then the conversion price is the lesser of the stated price of $0.25 or the market price (as calculated pursuant to the Agreement). Pursuant to the terms of the SPA and the Note, the Company is required to reserve and keep available out of its authorized and unissued shares of common stock a number of shares of common stock at least equal to three (3) times the number of shares issuable on conversion of the Note.

The Company determined that the conversion feature met the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. For the three months ended March 31, 2019 and 2018, the Company determined that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there wasn’t a derivative liability associated with this convertible note. The Company recognized a debt discount on the notes as a reduction (contra-liability) to the Convertible Notes Payable and the discounts are being amortized over the life of the notes.

The Note became due and payable on January 13, 2018 and the Company is in default of its obligations under the Note. Interest on the Note is being accrued at the default rate of 22% per annum beginning on July 6, 2018 and the Company classified the Note as a current liability. On November 2, 2018, the Note Holder demanded payment of all amounts due under the Note plus applicable collection costs, including attorney’s fees at the Mandatory Default Amount. The Mandatory Default Amount means the greater of (a) the Outstanding Balance divided by the Installment Conversion Price on the date the Mandatory Default Amount is demanded, multiplied by the VWAP on the date the Mandatory Default Amount is demanded, or (b) the Outstanding Balance following the application of the Default Effect. Pursuant to the demand letter on that date, the Company owed $125,053, which includes the mandatory default amount and interest will continue to accrue at the rate of $78.80 per day. The principal increase is considered applied as of the date of the demand for payment and is not tacked back to the Issue Date of the Note.

Pursuant to the terms of the SPA and the Note, the Company is required to reserve and keep available out of its authorized and unissued shares of common stock a number of shares of common stock at least equal to three (3) times the number of shares issuable on conversion of the Note. The Company will have insufficient common shares authorized to cover the aggregate reserve requirement of all notes in default. As of March 31, 2019, the Company owed $124,650 in principal, $18,528 in interest, and the equivalent number of shares the Company would be required to issue to satisfy the Note is 572,712. As of December 31, 2018, the Company owed $124,650 in principal and accrued interest of $11,766.

XML

Warrant Liabilities

3 Months Ended

Mar. 31, 2019

Warrant Liabilities

9. Warrant Liabilities

9. Warrant Liabilities

The Company estimates the fair value of each option award on the date of grant using the Binomial option valuation model that uses the assumptions noted in the table below. Because Binomial option valuation models incorporate ranges of assumptions for inputs, those ranges are disclosed. Expected volatilities are based on the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model; separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from certain groups of employees exhibiting different behavior. During the year ended December 31, 2018, management determined that the Company’s common stock lacked liquidity and market value and therefore no derivative liability was recorded in association with these warrants.

The following table sets forth common share purchase warrants outstanding as of March 31, 2019:

	March 31, 2019		December 31, 2018
Warrants, January 1		66		122
Additions		---		---
Conversions		---		(4	)
Forfeitures		---		(52	)
Warrants, balance		66		66

			Weighted
			Average
			Exercise		Intrinsic
	Warrants		Price		Value
Outstanding, January 1		66	$	7.74	$	7.66
Warrants granted and issued		---	$	---	$	---
Warrants forfeited		---	$	---	$	---
Outstanding, March 31		66	$	7.74	$	7.66
Common stock issuable upon exercise of warrants		984,714	$	0.0034	$	0.80

Warrants Outstanding								Warrants Exercisable
				Weighted
		Number		Average		Weighted		Number		Weighted
		Outstanding		Remaining		Average		Exercisable		Average
Exercise		at March 31,		Contractual		Exercise		at March 31,		Exercise
Price		2019		Life (Years)		Price		2019		Price
$	0.20		66		0.65	$	0.0034		66	$	0.0034

The warrants convert at a rate of $0.20 per warrant, based on anti-dilution adjustments to the exercise price.

On July 5, 2017, the Company entered into a Securities Purchase Agreement and related documents with an institutional accredited investor. On the Closing Date, the Company issued to Investor a Convertible Promissory Note in the principal amount of $175,000 in exchange for payment by Investor of $157,500. In connection with the Financing, and in addition to the Securities Purchase Agreement and the Secured Convertible Promissory Note, the Company issued a Warrant (“Warrant 1”) which grants the investor the right to purchase at any time on or after each tranche, and for a period of five years thereafter, a number of fully paid and non-assessable shares of the Company’s common stock equal to the amount of each tranche received under the Note divided by $0.05, as adjusted from time to time pursuant to the terms and conditions of the Warrant. The conversion option and the outstanding common stock warrants on that date are classified as derivative liabilities at their fair value on the date of issuance. During the year ended December 31, 2017, the Company received a tranche of $35,000; resulting in the issuance of a warrant to purchase 70 shares of the Company’s common stock at $5,000 per share, resulting in an exercise value at issuance of $350,000. The relative fair value of the warrant at issuance was $12,565, which was recorded as a debt discount and amortized over the life of the note.

The Company estimates the fair value at each reporting period using the Binomial Method. During the year ended December 31, 2018, management determined that the Company’s common stock lacked liquidity and market value and therefore no derivative liability was recorded in association with these warrants and in quarter ending March 31, 2018, the Company recorded a gain on the write-off of the fair value of the warrant in the amount of $35,047.

The Warrant may be exercised in whole or in part at $5,000 per share, subject to anti-dilution adjustments set forth in the Agreement. If the Market Price is greater than the Exercise Price, the Warrant Holder may elect to receive Warrant shares pursuant to a cashless exercise. The Market Price means the highest traded price of the Company’s common stock during the twenty (20) trading days prior to the date of the respective Exercise Notice. A dilutive issuance occurs when the Company issues common stock at an effective price per share that is less than the then-current Exercise Price. In this event, the Exercise Price is adjusted to match the lowest price per share at which such Common Stock was issued or may be acquired in the dilutive issuance.

The Company is required to reserve and keep available out of its authorized and unissued shares of common stock a number of shares of common stock equal to five (5) times the number of shares issuable on conversion of the Warrant. As of March 31, 2019, the Company is in technical default of its Reserve requirement for the detached Warrant.

During the three months ended March 31, 2019, no warrants were exercised. The warrant derivative liability as of March 31, 2019 and December 31, 2018 was $0 and $0, respectively. As of March 31, 2019, the remaining equivalent number of shares the Company would be required to issue under a cashless exercise of the Warrant is estimated to be 984,714 shares, which is based upon an exercise price of $0.20.

On March 13, 2017, the Company entered into an Agreement with an institutional Lender. On that date, the Company issued to the Lender a Secured Convertible Promissory Note in the principal amount of $230,000; of which, the Company has received $150,000 as of December 31, 2017. In connection with the Financing, and in addition to the Securities Purchase Agreement and the Secured Convertible Promissory Note, the Company issued a Warrant (“Warrant 2”) which grants the right to purchase at any time on or after March 13, 2017 and for a period of three years, a number of fully paid and non-assessable shares of the Company’s common stock equal to $57,500 divided by the Market Price as of the issue date. The Market Price is the conversion factor multiplied by the average of the three lowest closing bid prices during the twenty trading days immediately preceding the applicable conversion. If the average of the three lowest closing bid prices is below $0.10, then the conversion factor is permanently reduced by 10%. If at any time the Company is not DTC eligible, then the conversion factor is further reduced by an additional 5%. At any time prior to the expiration date, the investor may elect a cashless exercise for any warrant shares equal to (i) the excess of the Current Market Value (Trade Price times the number of exercise shares) over the aggregate Exercise Price of the Exercise Shares, divided by (ii) the Adjusted Price (the lower of the Exercise Price of $0.25 or Market Price). The Trade Price is the higher of the closing trade price on the issue date or the VWAP of the stock for the trading day that is two trading days prior to exercise date. The conversion option and the outstanding common stock warrants on that date are classified as derivative liabilities at their fair value on the date of issuance. Under ASC-815 the conversion options embedded in notes payable require liability classification because the note does not contain an explicit limit to the number of shares that could be issued upon settlement.

The Market Price, as calculated pursuant to the Warrant Agreement, was $1,097 per share with 52 being the resulting number of warrant shares at issuance. The relative fair value of the warrant at issuance was $0, resulting in no debt discount. The Company estimates the fair value at each reporting period using the Binomial Method. As of March 31, 2018, management determined that the Company’s common stock lacked liquidity and market value and therefore no derivative liability was recorded in association with these warrants. As a result, the Company recorded a gain on the write-off of the fair value of the warrant in the amount of $2,779. The warrant derivative liability as of March 31, 2019 and March 31, 2018 was $0 and $0, respectively. Effective July 20, 2018, the warrant to purchase shares previously issued under the Convertible Promissory Note was terminated by the Warrant holder to facilitate the Company’s fundraising efforts.

The following table indicates the fair value of the warrants recorded by the Company at issuance.

	Amount		Factor		Warrant Shares		Stock Price on Date of Grant		Fair Value at Issuance		Fair Value as of December 31, 2017
Warrant 1	$	35,000	$	500		70	$	300	$	12,565	$	32,268
Warrant 2	$	57,500	$	1,097		52	$	900	$ -0-		$	2,779
Total	$	92,500				122			$	12,565	$	35,047

XML

Derivatives and Fair Value

3 Months Ended

Mar. 31, 2019

Restatement of financial statements

10. Derivatives and Fair Value

10. Derivatives and Fair Value

The Company evaluated the terms of the convertible notes, in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock and determined that the underlying is indexed to the Company’s common stock. The Company determined that the conversion features meet the definition of a liability and therefore bifurcated the conversion feature and accounted for it as a separate derivative liability. The Company evaluated the conversion feature for the embedded conversion option. Since these notes contain conversion price adjustment provisions (i.e. down round, or ratchet provisions), the Company determined that the embedded conversion options met the definition of a derivative. The effective conversion price was compared to the market price on the date of the note and was deemed to be less than the market value of underlying common stock at the inception of the note. The Company recognized a debt discount on the notes as a reduction (contra-liability) to the Convertible Notes Payable. The debt discounts are being amortized over the life of the notes. The Company recognized financing costs for charges by the lender for original issue discounts and other applicable administrative costs, normally withheld from proceeds, which are being amortized as finance costs over the life of the loan. The derivative values are calculated using the Binomial method.

As of March 31, 2019 and December 31, 2018, the Company had convertible notes payable outstanding in which the conversion rate was variable and undeterminable; however, the Company determined that there was no active market for the Company’s common stock and because of this lack of liquidity and market value, there was no derivative liability associated with the convertible notes. The Company uses judgment in determining the fair value of derivative liabilities at the date of issuance and at every balance sheet thereafter and in determining which valuation method is most appropriate for the instrument, the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate, if any.

ASC 825-10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 825-10 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 describes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities; Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. The Company’s Level 3 liabilities consist of the derivative

liabilities associated with the convertible notes. At March 31, 2019 and December 31, 2018, all of the Company’s derivative liabilities were categorized as Level 3 fair value liabilities. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

Level 3 Valuation Techniques

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. At the date of the original transaction, we valued the convertible note that contains down round provisions using a Black-Scholes model, with the assistance of a valuation consultant, for which management understands the methodologies. This model incorporates transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior. Using assumptions, consistent with the original valuation, the Company has subsequently used the Binomial model for calculating the fair value.

XML

Equity

3 Months Ended

Mar. 31, 2019

Equity

11. Equity

11. Equity

Stock Compensation

On March 31, 2019, the Company’s Board of Directors authorized the issuance of 15,000,000 shares to the Company’s Chief Executive Officer as a performance bonus pursuant to his employment agreement. The shares were valued at $0.20, the quoted market price on the date of issuance, or $3,000,000.

On March 1, 2018, the Company issued449,065 shares of the Company’s Series A Preferred Shares to its sole director and chief executive officer for a value of $112,266, or $2,500 per share. The value was recorded against his accrued compensation payable.

On January 23, 2018, the Company issued 1,000 shares of its common stock to sole officer and director, Robert DeAngelis, as his 2017 annual bonus per his employment agreement. The annual bonus, if any, is determined and paid in accordance with policies set from time to time by the Board or Directors, in its sole discretion. The Board’s policy has been to base the stock price for such issuances upon the average of the closing price of the preceding 10 trading days as reported on OTC Markets website, which was $33.00; rendering the value of the preferred issued as $330,000. Since the Company’s closing stock price on the date of grant was also $33.00, the Company will not recognize any associated discounts or benefits associated with the shares issued.

Stock Issued for Debt and Interest

During the year ended December 31, 2018, the Company issued 31,745 shares of common stock, for a value of $86,811 in satisfaction of $37,101 principal, $39,710 accrued interest, and $10,000 in conversion fees on its convertible notes payable. The Company recorded the issuances at the contract value, at the date of exchange, off-setting the notes payable and accrued interest.

Preferred Stock

On March 1, 2018, the Company issued 45 shares of the Company’s non-convertible Series A Preferred Shares, with a par value of $0.0001 and with an initial liquidation preference of $200 per share pursuant to its amended and restated Articles on July 26, 2016, at a price of $200 per share, to its sole director and chief executive officer in exchange for $112,266 of accrued compensation. The Company valued the transaction at $8981 and recognized the difference in fair value to additional paid in capital.

Warrants

On the July 10, 2017, and in connection with a Securities Purchase Agreement and a Secured Convertible Promissory Note, the Company issued a Warrant which grants the investor the right to purchase at any time on or after July 10, 2017, and for a period of five years thereafter, a number of fully paid and non-assessable shares of the Company’s common stock equal to the amount of the tranche received under the Note divided by $500. The conversion price is $0.50, as adjusted from time to time pursuant to the terms and conditions of the Warrant. As of December 31, 2017, the Company received a tranche of $35,000; resulting in the issuance of a warrant to purchase 70 shares of the Company’s common stock. The relative fair value of the warrant at issuance was $12,565. The Company estimates the fair value at each reporting period using the Binomial Method. For the three months ended March 31, 2019, management determined that the Company’s common stock lacked liquidity and market value and therefore no derivative liability was recorded in association with these warrants. The warrant derivative liability as of March 31, 2019 and 2018 was $0 and $0, respectively. During year ended December 31, 2018, the Warrant Holder, in a cashless exercise, was issued 6,032 shares of common stock for an aggregate value of $9,456 pursuant to anti-dilution terms of the Warrant that adjusted the conversion price.

On the March 13, 2017, and in connection with a Securities Purchase Agreement and a Secured Convertible Promissory Note, the Company issued a Warrant which grants the investor the right to purchase at any time on or after March 13, 2017, and for a period of three years thereafter, a number of fully paid and non-assessable shares of the Company’s common stock equal to $57,500 divided by the Market Price as of March 13, 2017. The Market Price, as calculated pursuant to the Warrant Agreement, was $1,097 per share with 52 being the resulting number of warrant shares at issuance. The relative fair value of the warrant at issuance was $47,174, resulting in a debt discount equal to $10,326 which will be amortized over the life of the Warrant. The Company estimates the fair value at each reporting period using the Binomial Method. The warrant derivative liability as of March 31, 2019 and 2018 was $0 and $0, respectively. Made effective on July 20, 2018, the warrant to purchase shares previously issued under the Convertible Promissory Note was terminated by the Warrant holder to facilitate the Company’s fundraising efforts.

Other

During the three months ended March 31, 2019 and 2018, the Company recorded in-kind contributions for rent expense in the amount of $300 and $300, respectively.

Amendment to the Articles of Incorporation

Pursuant to a written consent in lieu of a meeting, dated January 21, 2019, the Board approved to amend our Articles of Incorporation to (i) effect a 1-for-10,000 reverse stock split of our issued and outstanding shares of Common Stock, par value $0.00001 per share, and (ii) decrease the amount of authorized shares of Common Stock from 9.999 billion (9,999,000,000) prior to the Reverse Stock Split to 200 million (200,000,000). The Company has retro-actively applied the reverse stock split made effective on March 1, 2019 to these financial statements. 

As of March 31, 2019, the total number of shares this corporation is authorized to issue is 200,000,000 (two-hundred million), allocated as follows among these classes and series of stock:

Designation	Par value		Shares Authorized
Common	$	0.00001		200,000,000
Preferred Stock Class, Series A	$	0.0001		500,000
Preferred Stock Class, Series B	$	0.0001		500,000

On February 20, 2018, the Board of Directors recommended and the majority shareholder (holding 83% of the voting shares) voted in favor of increasing the authorized capital of the Company from Three Billion (3,000,000,000) shares, to Ten Billion (10,000,000,000) shares. No change was made to the number of preferred shares authorized. Accordingly, as of February 20, 2018, the total authorized capital of the Company will be comprised of Nine Billion Nine Hundred Ninety-Nine Million (9,999,000,000) shares of common stock, par value $0.00001 per share, and One Million (1,000,000) shares of Preferred Stock, of which Five Hundred Thousand (500,000) shares are designated as Series A Preferred Stock, par value $0.0001 per share.

On February 5, 2018, the Board of Directors recommended and the majority shareholder (holding 74% of the voting shares) voted in favor of increasing the authorized capital of the Company from One Billion (1,000,000,000) shares, to Three Billion (3,000,000,000) shares. No change was made to the number of preferred shares authorized. Accordingly, as of February 5, 2018, the total authorized capital of the Company will be comprised of Two Billion Nine Hundred Ninety-Nine Million (2,999,000,000) shares of common stock, par value $0.00001 per share, and One Million (1,000,000) shares of Preferred Stock, of which Five Hundred Thousand (500,000) shares are designated as Series A Preferred Stock, par value $0.0001 per share.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies

12. Commitments and Contingencies

12. Commitments and Contingencies

From time to time the Company may be a party to litigation matters involving claims against the Company. Management believes that there are no known or potential matters that would have a material effect on the Company’s financial position or results of operations.

The Company’s operations are subject to significant risks and uncertainties including financial, operational and regulatory risks, including the potential risk of business failure.

There were no operating or capital lease commitments as of March 31, 2019 and March 31, 2018.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2019

Subsequent Events

13. Subsequent Events

13. Subsequent Events

The Company has evaluated all events that occur after the balance sheet date through the date when the financial statements were issued to determine if they must be reported.

On April 10, 2019, the Company entered into a Joint Venture Agreement with a third party for purposes of building a digital platform for real estate transactions. The parties have agreed that any projects undertaken jointly from which any funds are raised through the joint venture shall be split 50% to the Company and 50% to the third party. For and in consideration of the services to be provided, the Company has issued 1,250,000 shares of common stock. The shares were valued at $0.55, the quoted market price on the date of issuance, or $687,500.

On April 10, 2019, the Company entered into a Consulting Agreement with a third party for purposes of establishing real estate management and real estate holding divisions. The Company has agreed to dedicate a minimum of thirty-three percent (33%) of all funds received by the Company to the new division. The term of the Agreement is for a period of twelve months and is automatically extended for successive three month terms. For and in consideration of the services to be provided, the Company has issued 1,250,000 shares of common stock. The shares were valued at $0.55, the quoted market price on the date of issuance, or $687,500.

On December 20, 2019, the Company entered into a securities purchase agreement with Auctus Fund, LLC, a Delaware limited liability company. The SPA provides for the purchase by Actus of a senior secured convertible promissory note in the principal amount of $1,100,000 and a warrant to purchase common stock issued by the Company. On January 15, 2020, the Company authorized the disbursement of the proceeds of this $1,100,000 Note to Florida Beauty Flora, Inc.. The Promissory Note matures on December 20, 2020 and bears interest at a rate of 12% per annum.

On December 26, 2019, we entered into a definitive agreement and plan of merger and reorganization with Florida Beauty Express Inc., Florida Beauty Flora Inc., Floral Logistics of Miami Inc., Floral Logistics of California Inc. and Tempest Transportation Inc. (collectively “Florida Beauty”), pursuant to which Florida Beauty may purchase all of the shares of stock of our Company held by Robert DeAngelis, our sole director and officer.

In December 2019, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries, including the United States, and infections have been reported globally.

The COVID-19 outbreak is a widespread health crisis that could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could materially impact our efforts to effectuate ordinary business transactions into the unforeseeable future. A pandemic typically results in social distancing, travel bans and quarantine, and this may limit access to our facilities, customers, management, support staff and professional advisors. These factors, in turn, may not only impact our operations, financial condition and demand for our goods and services but our overall ability to react timely to mitigate the impact of this event. In addition, it may hamper our efforts to comply with our filing obligations with the Securities and Exchange Commission.

Our business has been disrupted, but the extent to which the coronavirus impacts our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact. International stock markets have begun to reflect the uncertainty associated with the slow-down in the American, European, and Asian economies, and the significant decline in the Dow Industrial Average in February and March 2020, was largely attributed to the effects of COVID-19.

On January 7, 2020, 100,000 shares of the Company’s common stock were issued to its President and Chief Executive Officer pursuant to the Plan of Share Exchange Agreement originally entered into on December 27, 2019 with Florida Beauty Express, Inc., Florida Beauty Flora, Inc., Floral Logistics of Miami, Inc., Floral Logistics of California, Inc., and Tempest Transportation Inc.

On January 13, 2020, we entered into an Amended Agreement and Plan of Share Exchange Agreement (the “Agreement”) by and Amongst, REAC Group, Inc. (“REAC”) and Florida Beauty Express, Inc., Florida Beauty Flora, Inc., Floral Logistics of Miami, Inc., Floral Logistics of California, Inc., Tempest Transportation Inc. (the “Companies”). The Agreement is for the exchange of 100% of the outstanding shares of the Companies in exchange for 15,015,002 shares of REAC Common Stock and 500,000 shares of REAC Series A Preferred Stock. The Agreement also states that the Mr. Robert DeAngelis will return to the REAC Treasury all of the shares that he currently controls, in return for $350,000, to be paid as follows: $100,000 shall be paid in cash within three (3) days of closing by wired funds to Robert DeAngelis, (the “Closing Cash”), and the remaining $150,000 will be payable in $75,000 installments for the first two quarters after closing (March 31, 2020 and June 30, 2020 respectively) and Mr. DeAngelis will also receive 100,000 shares of common stock, that will be valued at $1.00 per share, respectively. As part of the Agreement, Mr. Robert DeAngelis will also resign and appoint new officers and directors as to be chosen by the Companies.

On February 3, 2020, the Company entered into a Senior Convertible Promissory Note in the amount of $277,750 and the Company authorized the disbursement of the proceeds to Florida Beauty Flora, Inc. The Note bears interest at a rate of 12% and matures one year from the purchase date. The Note is convertible into shares of the Company’s common stock at a conversion price equal to 50% multiplied by the lowest trading price during the previous twenty-five (25) days. At any time during the period beginning on the Issue Date and ending on the last Trading Day immediately preceding the Maturity Date, the Borrower shall have the right, exercisable on not less than three (3) Trading Days prior written notice to the Holder of the Note and subject to the Holder’s written consent at the time of such prepayment, to prepay the outstanding Note (principal and accrued interest), in full by making a payment to the Holder of an amount in cash equal to 150%, multiplied by the sum of the then outstanding principal amount of this Note, plus accrued and unpaid interest on the unpaid principal amount of the Note, plus Default Interest, if any.

On February 14, 2020, the Company issued 500,000 shares of common stock to its President and Chief Executive Officer as a performance bonus for the year ending December 31, 2019. The shares were valued at the quoted market price on the date of issuance.

On February 25, 2020, the Company issued 1,000,000 shares of common stock to its President and Chief Executive Officer as a performance bonus for 2020. The shares were valued at the quoted market price on the date of issuance.

On April 13, 2020, we entered into a second Amended Agreement and Plan of Share Exchange Agreement that was originally entered into on December 26, 2019 (the “Agreement”) by and Amongst, REAC Group, Inc. (“REAC”) and Florida Beauty Express, Inc., Florida Beauty Flora, Inc., Floral Logistics of Miami, Inc., Floral Logistics of California, Inc., Tempest Transportation Inc. (the “Companies”) and Companies shareholders. The Agreement is for the exchange of 100% of the outstanding shares of the Companies in exchange for 15,015,002 shares of REAC Common Stock and 500,000 shares of REAC Series A Preferred Stock. The Conditions to the Agreement have been satisfied and fully closed, and the Companies are now wholly-owned subsidiaries of REAC. The Agreement also states that Mr. Robert DeAngelis will return to the REAC Treasury all of the shares that he currently controls, in return for $350,000, to be paid as follows: $100,000 shall be paid in cash within three (3) days of closing by wired funds to Robert DeAngelis, (the “Closing Cash”), the Closing Cash has been paid, and the remaining $150,000 will be payable in $75,000 installments for the first two quarters after closing (April 30, 2020 (of which $12,000 has been paid) and June 30, 2020 respectively) and Mr. DeAngelis will also receive 100,000 shares of common stock, that will be valued at $1.00 per share, respectively. As part of the Agreement, Mr. Robert DeAngelis will also resign and appoint new officers and directors as to be chosen by the Companies. The Company plans to bring Mr. DeAngelis back as a consultant and / or an advisor, but no agreements have been made to do so, at this time.

The 15,015,002 shares of Common Stock and 500,000 shares of Preferred Stock will be distributed as described below:

Common Stock

Shares to Issue	Shareholder
1,876,875	Efrat Afek
1,876,875	Ralph Milman
3,753,751	Ronan Koubi
3,003,000	The Q Trust
2,552,551	Ronald Minsky
1,951,950	The Apollo Family Trust

Series A Preferred Stock

Shares to Issue	Shareholder
62,500	Ralph Milman
62,500	Efrat Afek
125,000	Ronan Koubi
105,000	The Q Trust
80,000	Ronald Minsky
65,000	The Apollo Family Trust

The Agreement may be terminated, and the Acquisition contemplated herein may be abandoned at any time prior to the Effective Time, whether before or after stockholder approval thereof by either Acquiror or the Companies.

On April 16, 2020, the Company issued 400,000 shares of common stock to its President and Chief Executive Officer pursuant to the terms of his employment agreement. The shares were issued as a performance bonus for 2020 and were valued at the quoted market price on the date of issuance.

On April 23, 2020, the Company issued 2,000,000 shares of common stock to its President and Chief Executive Officer pursuant to the terms of his employment agreement. The shares were issued as a performance bonus for 2020 and were valued at the quoted market price on the date of issuance.

Effective June 22, 2020, Robert DeAngelis resigned from his position as President and Chief Executive Officer and as a member of the board of directors of REAC Group, Inc. Ronen Koubi will be appointed the new CEO. Ronen Koubi is the President and Director of Florida Beauty Flora, Inc.

Effective July 29, 2020, the Company entered into a securities purchase agreement with Auctus Fund, LLC, a Delaware limited liability company. The SPA provides for the purchase by Auctus of a convertible promissory note in the principal amount of $575,000; including 100% warrant coverage with full anti-dilution rights and buyback option. The Company authorized the disbursement of the proceeds of this Note to Florida Beauty Flora, Inc.. The Promissory Note matures on July 29, 2021 and bears interest at a rate of 12% per annum.

Effective October 12, 2020, one of the Company’s convertible promissory notes dated March 13, 2017, with the original principal amount of $230,000, was assigned to a new third party. All rights, title, and interest of the Note were assigned without recourse and without representations or warranties of any kind.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2019

Summary of Significant Accounting Policies

Basis of Presentation

The Balance Sheet as of March 31, 2019, the Statements of Income for the three months ended March 31, 2019 and 2018, the Statements of Stockholders’ Deficit for the three months ended March 31, 2019 and 2018, and the Statements of Cash Flows for the three months ended March 31, 2019 and 2018 are unaudited. These unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP). In our opinion, the unaudited interim financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of March 31, 2019, our results of operations for the three months ended March 31, 2019 and 2018, and our cash flows for the three months ended March 31, 2019 and 2018. The results of operations for the three months ended March 31, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019.

These unaudited interim financial statements should be read in conjunction with the financial statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC.

All share and per share information contained in this report gives retroactive effect to a 1 for 10,000 reverse stock split of outstanding common stock, effective March 1, 2019.

Use of Estimates

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Our most significant estimates are for stock based compensation; assumptions used in calculating derivative liabilities, and deferred tax valuation allowances. We evaluate our estimates on an ongoing basis. Actual results may differ from these estimates under different assumptions or conditions.

Financial Instruments

The Company’s balance sheets include the following financial instruments: cash, accrued expenses, notes payable and payables to a stockholder. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. The carrying values of the notes payable and amounts due to stockholder approximates fair value based on borrowing rates currently available to the Company for instruments with similar terms and remaining maturities.

FASB Accounting Standards Codification (ASC) topic, “Fair Value Measurements and Disclosures”, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

· Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities

· Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

· Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2019.

Derivative Liabilities

The Company assessed the classification of its derivative financial instruments as of March 31, 2019 and 2018, which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815.

During the three months ended March 31, 2019 and 2018, respectively, the Company had notes payable outstanding in which the conversion rate was variable and undeterminable. The Company uses judgment in determining the fair value of derivative liabilities at the date of issuance and at every balance sheet thereafter and in determining which valuation method is most appropriate for the instrument, the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate, if any. For the three months ended March 31, 2019, the Company determined that there was no active market for the Company’s common stock, and because of this lack of liquidity and market value, there was no derivative liability associated with these convertible notes for the period.

Beneficial Conversion Features

ASC 470-20 applies to convertible securities with beneficial conversion features that must be settled in stock and to those that give the issuer a choice in settling the obligation in either stock or cash. ASC 470-20 requires that the beneficial conversion feature should be valued at the commitment date as the difference between the conversion price and the fair market value of the common stock into which the security is convertible, multiplied by the number of shares into which the security is convertible. This amount is recorded as a debt discount and amortized over the life of the debt. ASC 470-20 further limits this amount to the proceeds allocated to the convertible instrument.

Cash Flow Reporting

The Company follows ASC 230, Statement of Cash Flows, for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.

Cash and Cash Equivalents

Cash is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed on demand and, therefore, bear minimal risk. The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company had no cash equivalents at either March 31, 2019 or 2018.

Long-Lived Assets

In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-lived asset exceeds its fair value.

Stock Based Compensation

Under ASC 718, Compensation – Stock Compensation, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

Equity instruments (“instruments”) issued to other than employees are recorded on the basis of the fair value of the instruments, as required by FASB ASC 718. FASB ASC No. 505, Equity Based Payments to Non-Employees (“ASC 505”) defines the measurement date and recognition period for such instruments. In general, the measurement date is (a) when a performance commitment, as defined, is reached or (b) when the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant as defined in the ASC 505.

Income Taxes

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

Earnings Per Share

Basic income per common share is computed based upon the weighted average common shares outstanding as defined by FASB ASC No. 260, Earnings Per Share.

Diluted income per share includes the dilutive effects of stock options, convertible debt, warrants, and stock equivalents. To the extent stock options, stock equivalents and warrants are anti-dilutive; they are excluded from the calculation of diluted income per share. As of March 31, 2019, there were approximately 3,597,620 share equivalents for potential conversion demand of our outstanding convertible notes and warrants.

XML

Restatement of financial statements (Tables)

3 Months Ended

Mar. 31, 2019

Restatement of financial statements

Schedule of Statement of financials statement

The following reflects changes to the accounts affected as a result of the restatement:
Changes to the Balance Sheet	As originally filed			As restated			Change Increase/ (decrease)
Accrued Interest	$	50,165		$	78,677		$	28,513
Convertible Notes Payable	$	273,709		$	506,412		$	232,703
Changes to Other Income and Expense
Interest Expense	$	31,541		$	31,972		$	431
Debt financing penalties	$	---		$	14,094		$	14,094
Gain on Settlement of Debt	$	246,691		$	-		$	(246,691	)
The following reflects changes to the balance sheet as a result of the restatement:
Liabilities and Stockholders’ Deficit
Current liabilities	As originally filed			As restated			Change Increase/ (decrease)
Accounts payable	$	17,500		$	17,500		$	-
Accrued interest		50,165			78,677			28,513
Accrued salaries and taxes		931,948			931,948			-
Due to principle shareholder, related party		10,795			10,795			-
Convertible notes payable		273,709			506,412			232,703
Total current liabilities		1,284,117			1,545,332			261,215
Stockholders’ Deficit
Preferred Stock, Series A $.0001 par value, 500,000 shares authorized; none issued and outstanding		50			50			-
Preferred Stock, Series B $.001 par value, 500,000 shares authorized; none issued and outstanding		-			-			-
Common Stock, $0.00001 par value, 199,000,000 shares authorized15,057,517 and 9,364 issued and outstanding, respectively		150			150			-
Common stock payable		-			-			-
Additional paid-in capital		25,038,765			25,038,765			-
Accumulated deficit		(26,569,799	)		(26,584,036	)		(261,215	)
Total stockholders’ deficit	$	(1,530,834	)	$	(1,545,071	)	$	(261,215	)
The following reflects changes to net income and loss per share as a result of the restatement:
	As originally filed			As restated			Change Increase/ (decrease)
Net income/(loss)	$	(2,936,188	)	$	(3,197,403	)	$	(261,215	)
Loss per share, basic and dilutive	$	(0.70	)	$	(0.41	)	$	0.29
Weighted average shares outstanding, basic and dilutive		4,221,826			7,784,185			3,597,620

XML

Accrued Liabilities (Tables)

3 Months Ended

Mar. 31, 2019

Accrued Liabilities

Schedule of Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued expenses:
	March 31, 2019		December 31, 2018
Accounts payable	$	17,500	$	3,000
Accrued interest		78,677		54,119
Accrued salaries, payroll taxes, penalties and interest (a)		931,948		807,108
Due to principle shareholder, related party		10,795		---

XML

Convertible Notes Payable (Tables)

3 Months Ended

Mar. 31, 2019

Convertible Notes Payable

Schedule of Short-term Debt

	March 31, 2019		December31, 2018
Convertible promissory notes, various lending institutions, maturing at variable dates ranging from 180 days to one year from origination date, 8-10% interest and in default interest of 12-24%, convertible at discount to trading price (25-50%) based on various measurements of prior trading, at face value of remaining original note principal balance plus default penalties, net of unamortized debt discounts, attributable to derivative liabilities, and deferred financing costs in the amount of $-0- and $6,974, respectively.	$	506,412	$	493,738
Principal		506,412		493,738
Debt discount		---		(4,915	)
Total Principal	$	506,412	$	488,823

Summary of Convertible Note Transactions

Summary of Convertible Note Transactions:
	March 31, 2019			December31, 2018
Convertible notes, January 1	$	493,738		$	364,721
Additional notes, face value		-			65,000
Default Penalties		14,094			172,886
Settlement of debt		-			(20,000	)
Conversions of debt		(1,420	)		(88,869	)
Unamortized debt discounts		-			(4,915	)
Convertible notes, balance	$	506,412		$	488,823

XML

Warrant Liabilities (Tables)

3 Months Ended

Mar. 31, 2019

Warrant Liabilities

Schedule of common stock warrants outstanding

	March 31, 2019		December 31, 2018
Warrants, January 1		66		122
Additions		---		---
Conversions		---		(4	)
Forfeitures		---		(52	)
Warrants, balance		66		66

Schedule of warrant outstanding

			Weighted
			Average
			Exercise		Intrinsic
	Warrants		Price		Value
Outstanding, January 1		66	$	7.74	$	7.66
Warrants granted and issued		---	$	---	$	---
Warrants forfeited		---	$	---	$	---
Outstanding, March 31		66	$	7.74	$	7.66
Common stock issuable upon exercise of warrants		984,714	$	0.0034	$	0.80

Warrants Outstanding								Warrants Exercisable
				Weighted
		Number		Average		Weighted		Number		Weighted
		Outstanding		Remaining		Average		Exercisable		Average
Exercise		at March 31,		Contractual		Exercise		at March 31,		Exercise
Price		2019		Life (Years)		Price		2019		Price
$	0.20		66		0.65	$	0.0034		66	$	0.0034

Schedule of Fair Value of Warrant

	Amount		Factor		Warrant Shares		Stock Price on Date of Grant		Fair Value at Issuance		Fair Value as of December 31, 2017
Warrant 1	$	35,000	$	500		70	$	300	$	12,565	$	32,268
Warrant 2	$	57,500	$	1,097		52	$	900	$ -0-		$	2,779
Total	$	92,500				122			$	12,565	$	35,047

XML

Equity (Tables)

3 Months Ended

Mar. 31, 2019

Equity

Schedule of Classes and Series of Stock

Designation	Par value		Shares Authorized
Common	$	0.00001		200,000,000
Preferred Stock Class, Series A	$	0.0001		500,000
Preferred Stock Class, Series B	$	0.0001		500,000

XML

Subsequent Events (Tables)

3 Months Ended

Mar. 31, 2019

Subsequent Events

Schedule of common stock and preferred stock

Shares to Issue	Shareholder
1,876,875	Efrat Afek
1,876,875	Ralph Milman
3,753,751	Ronan Koubi
3,003,000	The Q Trust
2,552,551	Ronald Minsky
1,951,950	The Apollo Family Trust

Series A Preferred Stock

Shares to Issue	Shareholder
62,500	Ralph Milman
62,500	Efrat Afek
125,000	Ronan Koubi
105,000	The Q Trust
80,000	Ronald Minsky
65,000	The Apollo Family Trust

XML

Summary of Significant Accounting Policies (Details Narrative)	3 Months Ended
	Mar. 31, 2019 shares
Summary of Significant Accounting Policies
Reverse stock split	1 for 10,000
Potential dilutive securities excluded from computation of EPS	3,597,620

XML

Restatement of financial statements (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Accrued Interest	$ 78,677		$ 54,119
Interest Expense	31,971	$ 18,334
Change Increase/ (decrease) [Member]
Convertible Notes Payable	232,703
Accrued Interest	28,513
Interest Expense	431
Debt financing penalties	14,094
Gain on Settlement of Debt	(246,691)
As restated [Member]
Convertible Notes Payable	506,412
Accrued Interest	78,677
Interest Expense	31,972
Debt financing penalties	14,094
Gain on Settlement of Debt	0
As originally filed [Member]
Convertible Notes Payable	273,709
Accrued Interest	50,165
Interest Expense	31,541
Debt financing penalties	0
Gain on Settlement of Debt	$ 246,691

XML

Restatement of financial statements (Details 1) - USD ($)	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
Accounts payable	$ 17,500	$ 3,000
Accrued Interest	78,677	54,119
Accrued salaries and taxes	931,948	807,108
Due to principle shareholder, related party	585,089	542,942
Total current liabilities	1,545,332	1,353,050
Common Stock, $0.00001 par value, 199,000,000 shares authorized15,057,517 and 9,364 issued and outstanding, respectively	150	0
Additional paid-in capital	25,038,765	22,034,695
Accumulated deficit	(26,584,036)	(23,386,633)
Total stockholders' deficit	(1,545,071)	$ (1,351,888)	$ (1,068,877)	$ (1,200,879)
As originally filed [Member]
Accounts payable	17,500
Accrued Interest	50,165
Accrued salaries and taxes	931,948
Due to principle shareholder, related party	10,795
Convertible Notes Payable	273,709
Total current liabilities	1,284,117
Preferred Stock, Series A $.0001 par value, 500,000 shares authorized; none issued and outstanding	50
Preferred Stock, Series B $.001 par value, 500,000 shares authorized; none issued and outstanding	0
Common Stock, $0.00001 par value, 199,000,000 shares authorized15,057,517 and 9,364 issued and outstanding, respectively	150
Common stock payable	0
Additional paid-in capital	25,038,765
Accumulated deficit	(26,569,799)
Total stockholders' deficit	(1,530,834)
As restated [Member]
Accounts payable	17,500
Accrued Interest	78,677
Accrued salaries and taxes	931,948
Due to principle shareholder, related party	10,795
Convertible Notes Payable	506,412
Total current liabilities	1,545,332
Preferred Stock, Series A $.0001 par value, 500,000 shares authorized; none issued and outstanding	50
Preferred Stock, Series B $.001 par value, 500,000 shares authorized; none issued and outstanding	0
Common Stock, $0.00001 par value, 199,000,000 shares authorized15,057,517 and 9,364 issued and outstanding, respectively	150
Common stock payable	0
Additional paid-in capital	25,038,765
Accumulated deficit	(26,584,036)
Total stockholders' deficit	(1,545,071)
Change Increase/ (decrease) [Member]
Accounts payable	0
Accrued Interest	28,513
Accrued salaries and taxes	0
Due to principle shareholder, related party	0
Convertible Notes Payable	232,703
Total current liabilities	261,215
Preferred Stock, Series A $.0001 par value, 500,000 shares authorized; none issued and outstanding	0
Preferred Stock, Series B $.001 par value, 500,000 shares authorized; none issued and outstanding	0
Common Stock, $0.00001 par value, 199,000,000 shares authorized15,057,517 and 9,364 issued and outstanding, respectively	0
Common stock payable	0
Additional paid-in capital	0
Accumulated deficit	(261,215)
Total stockholders' deficit	$ (261,215)

XML

Restatement of financial statements (Details 2) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Net loss	$ (3,197,403)	$ (355,994)
Loss per share, basic and dilutive	$ (0.41)	$ (18.27)
Weighted average shares outstanding, basic and dilutive	7,784,185	19,486
As originally filed [Member]
Net loss	$ (2,936,188)
Loss per share, basic and dilutive	$ (0.70)
Weighted average shares outstanding, basic and dilutive	4,221,826
As restated [Member]
Net loss	$ (3,197,403)
Loss per share, basic and dilutive	$ (0.41)
Weighted average shares outstanding, basic and dilutive	7,784,185
Change Increase/ (decrease) [Member]
Net loss	$ (261,215)
Loss per share, basic and dilutive	$ 0.29
Weighted average shares outstanding, basic and dilutive	3,597,620

XML

Going Concern (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Going Concern
Net loss	$ (3,197,403)	$ (355,994)
Net Cash Used in Operating Activities	(11,696)	$ (38,724)
Accumulated Deficit	(26,584,036)		$ (23,386,633)
Working capital deficit	$ (1,545,071)

XML

Related Party Transactions (Details Narrative)	1 Months Ended	3 Months Ended
	Jan. 23, 2018 USD ($) integer $ / shares shares	Mar. 31, 2019 USD ($) $ / shares shares	Mar. 31, 2018 USD ($)	Dec. 31, 2018 USD ($) shares	Mar. 03, 2018 USD ($) shares	Mar. 02, 2018 shares	Feb. 20, 2018 shares	Feb. 05, 2018 shares	Mar. 04, 2013 USD ($)
Due to principal shareholder, related party		$ 10,795		$ 0	$ 0
Imputed interest rate		3.00%
Rent expense		$ 300	$ 300
Common stock, shares authorized | shares		200,000,000		200,000,000			9,999,000,000	2,999,000,000
Chief Executive Officer [Member]
Common stock, shares authorized | shares		15,000,000
Price per share | $ / shares		$ 0.20
Value of shares for performance bonus		$ 3,000,000
Compensation expense		30,000	30,000
Employment Agreement [Member] | Chief Executive Officer [Member]
Compensation expense		$ 30,000	$ 30,000
Due to related party, annual amount plus bonus									$ 120,000
Sole Officer and Director [Member]
Convertible trading days | integer	10
Convertible stock price | $ / shares	$ 33.00
Preferred stock, shares value	$ 330,000
Sole Officer and Director [Member] | Employment Agreement [Member]
Preferred stock, shares issued | shares	10,000
Convertible trading days | integer	10
Convertible stock price | $ / shares	$ 33.00
Preferred stock, shares value	$ 330,000
Closing stock price | $ / shares	$ 33.00
Sole Director and Chief Executive Officer [Member] | Series A Preferred Stock [Member]
Preferred stock, shares issued | shares					449,065	45
Preferred stock, shares value					$ 112,266

XML

Accrued Liabilities (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018	Mar. 03, 2018
Accounts Payable and Accrued expenses:
Accounts payable	$ 17,500	$ 3,000
Accrued Interest	78,677	54,119
Accrued salaries, payroll taxes, penalties and interest (a)	931,948	807,108
Due to principal shareholder, related party	$ 10,795	$ 0	$ 0

XML

Accrued Liabilities (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Accrued salaries, payroll taxes, penalties and interest	$ 931,948		$ 807,108
Chief Executive Officer [Member]
Accrued compensation	30,000	$ 30,000
Employment Agreement [Member] | Chief Executive Officer [Member]
Accrued compensation	$ 30,000	$ 30,000

XML

Convertible Notes Payable (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Accrued Liabilities
Convertible promissory notes	$ 506,412	$ 493,738
Principal	506,412	493,738
Debt discount	0	4,915
Total Principal	$ 506,412	$ 488,823

XML

Convertible Notes Payable (Details 1) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Accrued Liabilities
Convertible notes, January 1	$ 493,738	$ 364,721
Additional notes, face value	0	65,000
Default Penalties	14,094	172,886
Settlement of debt	0	(20,000)
Conversions of debt	(1,420)	(88,869)
Unamortized debt discounts	0	(4,915)
Convertible notes, balance	$ 506,412	$ 488,823

XML

Convertible Notes Payable (Details Narrative) - USD ($)										3 Months Ended			12 Months Ended
	Feb. 05, 2018	Oct. 06, 2017	Oct. 02, 2017	Jul. 10, 2017	Jul. 08, 2017	Jul. 05, 2017	May 05, 2017	Mar. 13, 2017	Mar. 13, 2017	Mar. 31, 2019	Mar. 30, 2019	Mar. 29, 2019	Dec. 31, 2018	Apr. 30, 2018	Dec. 31, 2017
Due to related party										$ 585,089			$ 542,942
Convertible notes, balance										506,412			493,738
Accrued Interest										78,677			54,119
Gain on extinguishment of debt										246,691
Debt extinguishment principal amount											$ 93,959	$ 64,650	37,101
Debt extinguishment accrued interest											$ 9,779		39,710
Interest rate	12.00%
Debt principal amount										$ 506,412			$ 493,738
Common stock, shares issued										15,057,517			50,441
Common stock value										$ 150			$ 0
Common shares issued, shares													31,745
Common shares issued, amount													$ 86,811
Penalty amount	$ 92,886									14,094		$ 60,000
Debt discount										$ 0			4,915
Convertible Note Payable [Member]
Accrued Interest													554
Debt principal amount													$ 10,696
Common stock shares issued for debt settlement										1,125
Debt settlement amount										$ 11,250
Cancellation of common stock shares										49			41,945
Convertible Promissory Note [Member] | Accredited Investor [Member]
Gain on extinguishment of debt		$ 20,589
Convertible conversion description		Each tranche paid under the Note matures in 12 months and is convertible into shares of the Company’s common stock after a period of six months at a conversion price equal to 50% of the lowest trading price per share during the previous ten (10) trading days					The Note matures in 10 months and is convertible into shares of the Company’s common stock at a conversion price equal to 50% of the lowest trading price per share during the previous twenty-five (25) trading days, subject to anti-dilution and market adjustments set forth in the Agreement.
Amount received		$ 150,000
Cancellation of common stock shares		50,000
Convertible Note Payable Two [Member]
Common stock shares issued for debt settlement													467
Debt settlement amount													$ 6,041
Legal fees													500
Securities Purchase Agreement [Member] | Accredited Investor [Member]
Common stock, shares issued							115
Common stock value							$ 63,415
Convertible conversion description							During the three months ended September 30, 2018, the Company was required to increase the principal balance of the note by $5,000 pursuant to Section 1.3 of the Agreement which states that if the Borrower does not maintain or replenish the Reserved Amount within three (3) business days of the request of the Holder, the principal amount will increase by $5,000 for each such occurrence. In addition, under Section 1.4(g) of the Note, the Company was required to increase the principal amount of the Note by $15,000 due to the conversion price being less than $0.01. The penalties are tacked back to the Issue Date of the Note.
Amount received							$ 165,000
Securities Purchase Agreement [Member] | Lenders [Member]
Interest rate								10.00%
Amount received													150,000
Warrants term period								3 years
Debt discount													20,000
Legal fees										$ 10,000
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note One [Member]
Warrants term period								3 years
Warrant per share								$ 1,097	$ 1,097
Market price of common stock								$ 57,500	$ 57,500
Debt discount								10,326	10,326
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note [Member]
Common stock value													$ 9,456
Common shares issued, shares													6,032
Convertible conversion description										The Note became due and payable on January 13, 2018 and the Company is in default of its obligations under the Note. Interest on the Note is being accrued at the default rate of 22% per annum beginning on July 6, 2018 and the Company classified the Note as a current liability. On November 2, 2018, the Note Holder demanded payment of all amounts due under the Note plus applicable collection costs, including attorney’s fees at the Mandatory Default Amount. The Mandatory Default Amount means the greater of (a) the Outstanding Balance divided by the Installment Conversion Price on the date the Mandatory Default Amount is demanded, multiplied by the VWAP on the date the Mandatory Default Amount is demanded, or (b) the Outstanding Balance following the application of the Default Effect. Pursuant to the demand letter on that date, the Company owed $125,053 and interest will continue to accrue at the rate of $78.80 per day.
Warrants term period				5 years
Warrant per share				$ 500
Market price of common stock								$ 57,500	$ 57,500
Conversion price per share								$ 0.25	$ 0.25
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note [Member] | Minimum [Member]
Capitalization costs									$ 6,000,000
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note Three [Member]
Convertible conversion description										Note became due and payable on July 5, 2018 and the Company is now in default of its obligations under the Note. Interest on the Note is being accrued at the default rate of 24% per annum and the Company classified the Note as a current liability. The Company is required to have authorized and reserved three and ten (10) times the number of shares that is actually issuable upon full exercise of the Note. The Note Holder could, at the Holder’s sole discretion, call the Note and impose the related default penalties. In this event, the Company would be obligated to pay 150% multiplied by the then outstanding entire balance
Securities Purchase Agreement [Member] | Warrants 1 [Member]
Convertible notes, balance						$ 175,000
Payment to accredited investor						$ 157,500
Securities Purchase Agreement [Member] | Warrants 1 [Member] | Secured Convertible Promissory Note [Member]
Warrants term period						5 years
Securities Purchase Agreement [Member] | Warrants 1 [Member] | Secured Convertible Promissory Note [Member] | Tranche [Member]
Amount received										$ 35,000
Warrant per share										$ 5,000
Securities Purchase Agreement [Member] | Warrant 2 [Member] | Secured Convertible Promissory Note One [Member]
Convertible notes, balance								$ 230,000	$ 230,000
Amount received															$ 150,000
Warrants term period								3 years
Warrant per share								$ 1,097	$ 1,097
Market price of common stock								$ 57,500	$ 57,500
Securities Purchase Agreement [Member] | Convertible Notes Payable Four [Member]
Due to related party													$ 275,129
Accrued Interest										$ 18,528			35,292
Debt principal amount													$ 5,480
Common shares issued, shares													3,300
Common shares issued, amount													$ 6,480
Convertible conversion description										During the three months ended September 30, 2018, the Company was required to increase the principal balance of the note by $5,000 pursuant to Section 1.3 of the Agreement which states that if the Borrower does not maintain or replenish the Reserved Amount within three (3) business days of the request of the Holder, the principal amount will increase by $5,000 for each such occurrence. In addition, under Section 1.4(g) of the Note, the Company was required to increase the principal amount of the Note by $15,000 due to the conversion price being less than $0.01. The penalties are tacked back to the Issue Date of the Note.
Common shares reserved for future issuance										1,618,558
Finance costs													1,000
Securities Purchase Agreement [Member] | Convertible Notes Payable Five [Member]
Due to related party										$ 160,823			124,650
Debt extinguishment principal amount										1,420
Debt extinguishment accrued interest										$ 1,500
Common shares issued, shares										4,900
Common shares issued, amount										$ 3,920
Penalty amount										$ 112,886
Convertible conversion description										The Note became due and payable on February 5, 2018 and the Company remains in default of its obligations under the Note. Interest on the Note is being accrued at the default rate of 12% per annum and the Company classified the Note as a current liability. The Company is required to have authorized and reserved three and one half (3.5) times the number of shares that is actually issuable upon full exercise of the Note. The Note Holder could, at the Holder’s sole discretion, call the Note and impose the related penalties. In this event, the Company would be obligated to pay 150% multiplied by the then outstanding entire balance for failing to pay at maturity. The Company would then have insufficient common shares authorized to cover the aggregate reserve requirement of all notes in default and an additional penalty would be imposed which obligates the Company to pay the then outstanding entire balance multiplied by 150% multiplied by a factor of two (2) for failing to maintain the required Reserved amount.
Finance costs										$ 1,000
Notes payable, related party													11,766
Securities Purchase Agreement [Member] | Convertible Promissory Note [Member]
Accrued Interest													$ 3,727
Interest rate			12.00%
Convertible conversion description			The Note is convertible into shares of the Company’s common stock after a period of 180 days at a conversion price equal to 61% multiplied by the average of the lowest two trading prices during the previous fifteen (15) days
Amount received			$ 53,000
Common stock shares issued for debt settlement										15,813
Debt settlement amount										$ 53,000
Securities Purchase Agreement [Member] | Convertible Promissory Note [Member] | Accredited Investor [Member]
Interest rate						5.00%
Debt principal amount						$ 175,000
Convertible conversion description						The Holder has the right at any time to convert all or any part of unpaid principal and interest into common shares of the Company equal to 50% multiplied by the Market Price; that being the lowest (1) trading price for the common stock during the twenty-five trading days prior to the conversion date, subject to anti-dilution and market adjustments set forth in the Agreement.
Payment to accredited investor						$ 157,500
Warrants term period						5 years
Warrant per share						$ 0.50
Debt discount						$ 17,500
Securities Purchase Agreement [Member] | Convertible Promissory Note [Member] | Lender [Member]
Debt principal amount								$ 230,000	$ 230,000
Securities Purchase Agreement [Member] | Warrant 1 [Member] | Secured Convertible Promissory Note [Member]
Warrants term period						5 years
Warrant per share						$ 5,000
Board of Directors [Member]
Due to related party										$ 124,650				$ 65,000
Convertible notes, balance														30,306
Accrued Interest														1,347
Debt principal amount														$ 28,959
Common shares issued, shares										572,712
Board of Directors [Member] | Convertible Note Payable [Member]
Convertible notes, balance					$ 27,846
Accrued Interest					$ 7,087
Interest rate					8.00%
Debt principal amount					$ 20,775
Common stock, shares issued					335					316,880
Common stock value					$ 3,350

XML

Warrant Liabilities (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Convertible Notes Payable
Warrants, January 1	66	122
Conversions		(4)
Forfeitures		(52)
Warrants, balance	66	66

XML

Warrant Liabilities (Details 1) - Warrants [Member]	3 Months Ended
	Mar. 31, 2019 $ / shares shares
Warrants/rights Outstanding, beginning | shares	66
Warrants/rights Outstanding, ending | shares	66
Warrants/rights Outstanding, Common stock issuable upon exercise of warrants | shares	984,714
Weighted Average Exercise Price, Outstanding at beginning of period	$ 7.74
Weighted Average Exercise Price, granted and issued	0.00
Weighted Average Exercise Price, Expired	0.00
Weighted Average Exercise Price, Outstanding at end of period	7.74
Weighted Average Exercise Price, Common stock issuable upon exercise of warrants	0.0034
Intrinsic value, Beginning balance	7.66
Intrinsic value, warrants granted and issued	0.00
Intrinsic value, Warrants forfeited	0.00
Intrinsic value, Ending balance	7.66
Intrinsic value, Common stock issuable upon exercise of warrants	$ 0.80

XML

Warrant Liabilities (Details 2) - Warrants 1 [Member]	3 Months Ended
	Mar. 31, 2019 USD ($) $ / shares shares
Common Stock Issuable Upon Exercise of Warrants Outstanding, Exercise Price	$ 0.20
Common Stock Issuable Upon Exercise of Warrants Outstanding, Number Outstanding | $	$ 66
Common Stock Issuable Upon Exercise of Warrants Outstanding, Weighted Average Remaining Contractual Life (Years)	7 months 24 days
Common Stock Issuable Upon Exercise of Warrants Outstanding, Weighted Average Exercise Price	$ 0.0034
Common Stock Issuable Upon Warrants Exercisable, Number Exercisable | shares	66
Common Stock Issuable Upon Warrants Exercisable, Weighted Average Exercise Price	$ 0.0034

XML

Warrant Liabilities (Details 3)	Dec. 31, 2018 USD ($) $ / shares shares
Fair value warrant amount	$ 92,500
Fair value warrant shares | shares	122
Fair value warrant at issuance	$ 12,565
Fair value warrant	35,047
Warrants 1 [Member]
Fair value warrant amount	$ 35,000
Fair value warrant shares | shares	70
Fair value warrant at issuance	$ 12,565
Fair value warrant	32,268
Fair value warrant factor	$ 500
Fair value warrant stock price on date of grant | $ / shares	$ 300
Warrants 2 [Member]
Fair value warrant amount	$ 57,500
Fair value warrant shares | shares	52
Fair value warrant at issuance	$ 0
Fair value warrant	2,779
Fair value warrant factor	$ 1,097
Fair value warrant stock price on date of grant | $ / shares	$ 900

XML

Warrant Liabilities (Details Narrative) - USD ($)							1 Months Ended	3 Months Ended	12 Months Ended
	Oct. 06, 2017	Oct. 02, 2017	Jul. 10, 2017	Jul. 05, 2017	May 05, 2017	Mar. 13, 2017	Mar. 31, 2017	Mar. 31, 2019	Dec. 31, 2017	Dec. 31, 2018
Convertible promissory note principal amount								$ 506,412		$ 493,738
Issuance of warrant to purchase shares										122
Convertible Promissory Note [Member] | Accredited Investor [Member]
Amount received	$ 150,000
Conversion description	Each tranche paid under the Note matures in 12 months and is convertible into shares of the Company’s common stock after a period of six months at a conversion price equal to 50% of the lowest trading price per share during the previous ten (10) trading days				The Note matures in 10 months and is convertible into shares of the Company’s common stock at a conversion price equal to 50% of the lowest trading price per share during the previous twenty-five (25) trading days, subject to anti-dilution and market adjustments set forth in the Agreement.
Warrants 1 [Member]
Issuance of warrant to purchase shares										70
Warrant per share										$ 0.0500
Common Stock Issuable Upon Exercise of Warrants Outstanding, Exercise Price								$ 0.20
Common Stock Issuable Upon Exercise of Warrants Outstanding								984,714
Warrants 2 [Member]
Issuance of warrant to purchase shares										52
Warrant per share										$ 0.1097
Warrants [Member]
Conversion description								The warrants convert at a rate of $0.20 per warrant, based on anti-dilution adjustments to the exercise price.
Securities Purchase Agreement [Member] | Accredited Investor [Member]
Amount received					$ 165,000
Conversion description					During the three months ended September 30, 2018, the Company was required to increase the principal balance of the note by $5,000 pursuant to Section 1.3 of the Agreement which states that if the Borrower does not maintain or replenish the Reserved Amount within three (3) business days of the request of the Holder, the principal amount will increase by $5,000 for each such occurrence. In addition, under Section 1.4(g) of the Note, the Company was required to increase the principal amount of the Note by $15,000 due to the conversion price being less than $0.01. The penalties are tacked back to the Issue Date of the Note.
Securities Purchase Agreement [Member] | Lenders [Member]
Amount received										$ 150,000
Warrants term period						3 years
Securities Purchase Agreement [Member] | Convertible Promissory Note [Member]
Amount received		$ 53,000
Conversion description		The Note is convertible into shares of the Company’s common stock after a period of 180 days at a conversion price equal to 61% multiplied by the average of the lowest two trading prices during the previous fifteen (15) days
Securities Purchase Agreement [Member] | Convertible Promissory Note [Member] | Accredited Investor [Member]
Payment to accredited investor				$ 157,500
Warrants term period				5 years
Warrant per share				$ 0.50
Conversion description				The Holder has the right at any time to convert all or any part of unpaid principal and interest into common shares of the Company equal to 50% multiplied by the Market Price; that being the lowest (1) trading price for the common stock during the twenty-five trading days prior to the conversion date, subject to anti-dilution and market adjustments set forth in the Agreement.
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note One [Member]
Issuance of warrant to purchase shares						52
Warrant fair value						$ 47,174
Warrant derivative liability								$ 0		0
Warrants term period						3 years
Warrant per share						$ 1,097
Market price of common stock						$ 57,500
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note [Member]
Issuance of warrant to purchase shares								70
Warrant fair value									$ 12,565
Warrant derivative liability								$ 0		0
Warrants term period			5 years
Warrant per share			$ 500
Market price of common stock						57,500
Conversion description								The Note became due and payable on January 13, 2018 and the Company is in default of its obligations under the Note. Interest on the Note is being accrued at the default rate of 22% per annum beginning on July 6, 2018 and the Company classified the Note as a current liability. On November 2, 2018, the Note Holder demanded payment of all amounts due under the Note plus applicable collection costs, including attorney’s fees at the Mandatory Default Amount. The Mandatory Default Amount means the greater of (a) the Outstanding Balance divided by the Installment Conversion Price on the date the Mandatory Default Amount is demanded, multiplied by the VWAP on the date the Mandatory Default Amount is demanded, or (b) the Outstanding Balance following the application of the Default Effect. Pursuant to the demand letter on that date, the Company owed $125,053 and interest will continue to accrue at the rate of $78.80 per day.
Securities Purchase Agreement [Member] | Warrants 1 [Member]
Convertible promissory note principal amount				$ 175,000
Payment to accredited investor				$ 157,500
Securities Purchase Agreement [Member] | Warrants 1 [Member] | Secured Convertible Promissory Note [Member]
Warrant fair value									12,565
Gain on write off warrant liability								$ 35,047
Warrant derivative liability								$ 0		0
Warrants term period				5 years
Warrant per share				$ 5,000
Common Stock Issuable Upon Exercise of Warrants Outstanding, Exercise Price								$ 0.20
Common Stock Issuable Upon Exercise of Warrants Outstanding								984,714
Market Price conversion description								Warrant may be exercised in whole or in part at $5,000 per share, subject to anti-dilution adjustments set forth in the Agreement. If the Market Price is greater than the Exercise Price, the Warrant Holder may elect to receive Warrant shares pursuant to a cashless exercise. The Market Price means the highest traded price of the Company’s common stock during the twenty (20) trading days prior to the date of the respective Exercise Notice.
Issuance of common stock									350,000
Securities Purchase Agreement [Member] | Warrants 1 [Member] | Secured Convertible Promissory Note [Member] | Tranche [Member]
Amount received								$ 35,000
Issuance of warrant to purchase shares								70
Warrant per share								$ 5,000
Securities Purchase Agreement [Member] | Warrants 2 [Member] | Secured Convertible Promissory Note One [Member]
Convertible promissory note principal amount						$ 230,000
Amount received									$ 150,000
Issuance of warrant to purchase shares						52
Warrant fair value						$ 0
Gain on write off warrant liability							$ 2,779
Warrant derivative liability								$ 0		$ 0
Warrants term period						3 years
Warrant per share						$ 1,097
Market price of common stock						$ 57,500

XML

Equity (Details) - $ / shares	Mar. 31, 2019	Dec. 31, 2018	Feb. 20, 2018	Feb. 05, 2018
Common Stock, Par Value	$ 0.00001	$ 0.00001	$ 0.00001	$ 0.00001
Common Stock, Shares Authorized	200,000,000	200,000,000	9,999,000,000	2,999,000,000
Preferred Stock, Shares Authorized			1,000,000	1,000,000
Preferred Stock A [Member]
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	500,000	500,000
Preferred Stock B [Member]
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	500,000	500,000

XML

Equity (Details Narrative)						1 Months Ended		3 Months Ended				12 Months Ended
	Mar. 02, 2018 USD ($) shares	Feb. 05, 2018 $ / shares shares	Jul. 10, 2017 $ / shares	Jul. 05, 2017 USD ($) $ / shares	Mar. 13, 2017 USD ($) $ / shares shares	Feb. 20, 2018 $ / shares shares	Jan. 23, 2018 USD ($) integer $ / shares shares	Mar. 31, 2019 USD ($) $ / shares shares	Mar. 30, 2019 USD ($)	Mar. 29, 2019 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2018 USD ($) $ / shares shares	Dec. 31, 2017 USD ($)	Mar. 03, 2018 USD ($) $ / shares shares	Mar. 01, 2018 $ / shares	May 05, 2017 USD ($)
Debt extinguishment principal amount									$ 93,959	$ 64,650		$ 37,101
Debt extinguishment accrued interest									$ 9,779			$ 39,710
Rent expense								$ 300			$ 300
Common stock issued, shares | shares												31,745
Common stock issued, amount												$ 86,811
Common stock value								150				0
Interest expense								31,971			$ 18,334
Conversion fees												10,000
Convertible promissory note principal amount								$ 506,412				$ 493,738
Issuance of warrant to purchase shares | shares												122
Equity voting investment ownership percentage		0.74%				0.83%
Articles of incorporation amendment description		the majority shareholder (holding 74% of the voting shares) voted in favor of increasing the authorized capital of the Company from One Billion (1,000,000,000) shares, to Three Billion (3,000,000,000) shares.				the Board of Directors recommended and the majority shareholder (holding 83% of the voting shares) voted in favor of increasing the authorized capital of the Company from Three Billion (3,000,000,000) shares, to Ten Billion (10,000,000,000) shares		Pursuant to a written consent in lieu of a meeting, dated January 21, 2019, the Board approved to amend our Articles of Incorporation to (i) effect a 1-for-10,000 reverse stock split of our issued and outstanding shares of Common Stock, par value $0.00001 per share, and (ii) decrease the amount of authorized shares of Common Stock from 9.999 billion (9,999,000,000) prior to the Reverse Stock Split to 200 million (200,000,000). The Company has retro-actively applied the reverse stock split made effective on March 1, 2019 to these financial statements.
Common Stock, Shares Authorized | shares		2,999,000,000				9,999,000,000		200,000,000				200,000,000
Common Stock, par value | $ / shares		$ 0.00001				$ 0.00001		$ 0.00001				$ 0.00001
Preferred Stock, shares authorized | shares		1,000,000				1,000,000
Debt discount								$ 0				$ 4,915
Warrants 1 [Member]
Issuance of warrant to purchase shares | shares												70
Warrant per share | $ / shares												$ 0.0500
Warrants 2 [Member]
Issuance of warrant to purchase shares | shares												52
Warrant per share | $ / shares												$ 0.1097
Series A Preferred Stock [Member]
Preferred Stock, shares authorized | shares		500,000				500,000
Preferred Stock, Par Value | $ / shares		$ 0.0001				$ 0.0001
Sole Officer and Director [Member]
Common stock issued, shares | shares							1,000
Price per share | $ / shares							$ 33.00
Preferred stock shares value							$ 330,000
Trading period | integer							10
Closing stock price | $ / shares							$ 33.00
Sole Officer and Director [Member] | Employment Agreement [Member]
Preferred stock shares issued | shares							10,000
Preferred stock shares value							$ 330,000
Trading period | integer							10
Closing stock price | $ / shares							$ 33.00
Sole Director and Chief Executive Officer [Member]
Preferred Stock, Par Value | $ / shares															$ 0.0001
Share issued for accrued compensation | shares	45
Liquidation preference per share | $ / shares															$ 200
Accrued compensation	$ 112,266
Transaction cost	$ 8,981
Sole Director and Chief Executive Officer [Member] | Series A Preferred Stock [Member]
Preferred stock shares issued | shares	45													449,065
Preferred stock shares value														$ 112,266
Preferred Stock, Par Value | $ / shares														$ 2,500
Securities Purchase Agreement [Member] | Warrants 1 [Member]
Convertible promissory note principal amount				$ 175,000
Securities Purchase Agreement [Member] | Accredited Investors [Member]
Common stock value																$ 63,415
Securities Purchase Agreement [Member] | Accredited Investor [Member]
Common stock value																$ 63,415
Securities Purchase Agreement [Member] | Lenders [Member]
Warrants term period					3 years
Debt discount												$ 20,000
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note [Member]
Common stock issued, shares | shares												6,032
Common stock value												$ 9,456
Issuance of warrant to purchase shares | shares								70
Price per share | $ / shares			$ 0.50
Proceeds from issuance of warrants													$ 35,000
Warrant fair value													12,565
Warrant derivative liability								$ 0				0
Warrants term period			5 years
Warrant per share | $ / shares			$ 500
Market price of common stock					$ 57,500
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note [Member] | Warrants 1 [Member]
Warrant fair value													$ 12,565
Warrant derivative liability								$ 0				0
Warrants term period				5 years
Warrant per share | $ / shares				$ 5,000
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note [Member] | Warrants 1 [Member] | Tranche [Member]
Issuance of warrant to purchase shares | shares								70
Warrant per share | $ / shares								$ 5,000
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note One [Member]
Issuance of warrant to purchase shares | shares					52
Warrant fair value					$ 47,174
Warrant derivative liability								$ 0				0
Warrants term period					3 years
Warrant per share | $ / shares					$ 1,097
Market price of common stock					$ 57,500
Debt discount					10,326
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note One [Member] | Warrants 2 [Member]
Convertible promissory note principal amount					$ 230,000
Issuance of warrant to purchase shares | shares					52
Warrant fair value					$ 0
Warrant derivative liability								0				$ 0
Warrants term period					3 years
Warrant per share | $ / shares					$ 1,097
Market price of common stock					$ 57,500
Securities Purchase Agreement [Member] | Convertible Notes Payable Five [Member]
Debt extinguishment principal amount								1,420
Debt extinguishment accrued interest								$ 1,500
Common stock issued, shares | shares								4,900
Common stock issued, amount								$ 3,920
Securities Purchase Agreement [Member] | Convertible Notes Payable Four [Member]
Common stock issued, shares | shares												3,300
Common stock issued, amount												$ 6,480
Securities Purchase Agreement [Member] | Convertible Promissory Note [Member] | Accredited Investor [Member]
Warrants term period				5 years
Warrant per share | $ / shares				$ 0.50
Debt discount				$ 17,500
Chief Executive Officer [Member]
Common Stock, Shares Authorized | shares								15,000,000
Value of shares for performance bonus								$ 3,000,000
Price per share | $ / shares								$ 0.20

XML

Subsequent Event (Details) - shares	Mar. 31, 2019	Dec. 31, 2018
Common Stock, shares to Issue	15,057,517	50,441
Efrat Afek [Member]
Common Stock, shares to Issue	1,876,875
Preferred stock shares issued	62,500
Ralph Milman [Member]
Common Stock, shares to Issue	1,876,875
Preferred stock shares issued	62,500
Ronan Koubi [Member]
Common Stock, shares to Issue	3,753,751
Preferred stock shares issued	125,000
The Q Trust [Member]
Common Stock, shares to Issue	3,003,000
Preferred stock shares issued	105,000
Ronald Minsky [Member]
Common Stock, shares to Issue	2,552,551
Preferred stock shares issued	80,000
The Apollo Family Trust [Member]
Common Stock, shares to Issue	1,951,950
Preferred stock shares issued	65,000

XML

Subsequent Events (Details Narrative) - USD ($)						1 Months Ended
	Apr. 13, 2020	Feb. 03, 2020	Jan. 15, 2020	Jan. 13, 2020	Apr. 10, 2019	Jul. 29, 2020	Dec. 20, 2019	Oct. 12, 2020	Apr. 23, 2020	Apr. 16, 2020	Feb. 25, 2020	Feb. 14, 2020	Jan. 07, 2020	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017	Jul. 10, 2017
Common stock shares	500,000
Preferred Stock shares	15,015,002
Convertible promissory note principal amount														$ 506,412	$ 493,738
Cash paid														$ 261	$ 1,162	$ 12,625	$ 51,396
Chief Executive Officer [Member]
Price per share														$ 0.20
Securities Purchase Agreement [Member] | Secured Convertible Promissory Note [Member]
Price per share																		$ 0.50
Subsequent Event [Member] | Convertible Note Payable [Member]
Original principal amount								$ 230,000
Subsequent Event [Member] | Chief Executive Officer [Member]
Common stock shares issued during the period									2,000,000	400,000	1,000,000	500,000	100,000
Subsequent Event [Member] | Florida Beauty Flora, Inc [Member] | Secured Convertible Promissory Note [Member]
Bears interest rate		12.00%
Convertible promissory note principal amount		$ 277,750
Cash payment percentage		150.00%
Conversion price percentage		50.00%
Subsequent Event [Member] | Florida Beauty Flora, Inc [Member] | Exchange Agreement [Member]
Common stock shares	500,000			500,000
Preferred Stock shares	15,015,002			15,015,002
Subsequent Event [Member] | Mr. Robert DeAngelis [Member] | Exchange Agreement [Member]
Common stock shares	100,000
Price per share	$ 1.00
Return amount	$ 350,000
Cash paid	100,000
Remaining balance	150,000
Installments payables	$ 75,000
Subsequent Event [Member] | Mr. Robert DeAngelis [Member] | Exchange Agreement 1 [Member]
Common stock shares				100,000
Price per share				$ 1.00
Return amount				$ 350,000
Cash paid				100,000
Remaining balance				150,000
Installments payables				$ 75,000
Subsequent Event [Member] | Consulting Agreement [Member]
Joint venture agreement funds description					The Company has agreed to dedicate a minimum of thirty-three percent (33%) of all funds received by the Company to the new division
Common stock shares issued for services, shares					1,250,000
Common stock shares issued for services, value					$ 687,500
Price per share					$ 0.55
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Auctus Fund, LLC [Member]
Common stock warrant purchase							$ 1,100,000
Bears interest rate						12.00%	12.00%
Convertible promissory note principal amount						$ 575,000
Warrant coverage percentage						100.00%
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Florida Beauty Flora, Inc [Member]
Disbursement of proceeds			$ 1,100,000
Subsequent Event [Member] | Joint Venture Agreement [Member]
Joint venture agreement funds description					The parties have agreed that any projects undertaken jointly from which any funds are raised through the joint venture shall be split 50% to the Company and 50% to the third party
Common stock shares issued for services, shares					1,250,000
Common stock shares issued for services, value					$ 687,500
Price per share					$ 0.55